1
|
Abuter R, Allouche F, Amorim A, Bailet C, Berdeu A, Berger JP, Berio P, Bigioli A, Boebion O, Bolzer ML, Bonnet H, Bourdarot G, Bourget P, Brandner W, Cao Y, Conzelmann R, Comin M, Clénet Y, Courtney-Barrer B, Davies R, Defrère D, Delboulbé A, Delplancke-Ströbele F, Dembet R, Dexter J, de Zeeuw PT, Drescher A, Eckart A, Édouard C, Eisenhauer F, Fabricius M, Feuchtgruber H, Finger G, Förster Schreiber NM, Garcia P, Garcia Lopez R, Gao F, Gendron E, Genzel R, Gil JP, Gillessen S, Gomes T, Gonté F, Gouvret C, Guajardo P, Guieu S, Hackenberg W, Haddad N, Hartl M, Haubois X, Haußmann F, Heißel G, Henning T, Hippler S, Hönig SF, Horrobin M, Hubin N, Jacqmart E, Jocou L, Kaufer A, Kervella P, Kolb J, Korhonen H, Lacour S, Lagarde S, Lai O, Lapeyrère V, Laugier R, Le Bouquin JB, Leftley J, Léna P, Lewis S, Liu D, Lopez B, Lutz D, Magnard Y, Mang F, Marcotto A, Maurel D, Mérand A, Millour F, More N, Netzer H, Nowacki H, Nowak M, Oberti S, Ott T, Pallanca L, Paumard T, Perraut K, Perrin G, Petrov R, Pfuhl O, Pourré N, Rabien S, Rau C, Riquelme M, Robbe-Dubois S, Rochat S, Salman M, Sanchez-Bermudez J, Santos DJD, Scheithauer S, Schöller M, Schubert J, Schuhler N, Shangguan J, Shchekaturov P, Shimizu TT, Sevin A, Soulez F, Spang A, Stadler E, Sternberg A, Straubmeier C, Sturm E, Sykes C, Tacconi LJ, Tristram KRW, Vincent F, von Fellenberg S, Uysal S, Widmann F, Wieprecht E, Wiezorrek E, Woillez J, Zins G. A dynamical measure of the black hole mass in a quasar 11 billion years ago. Nature 2024; 627:281-285. [PMID: 38286342 DOI: 10.1038/s41586-024-07053-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2023] [Accepted: 01/09/2024] [Indexed: 01/31/2024]
Abstract
Tight relationships exist in the local Universe between the central stellar properties of galaxies and the mass of their supermassive black hole (SMBH)1-3. These suggest that galaxies and black holes co-evolve, with the main regulation mechanism being energetic feedback from accretion onto the black hole during its quasar phase4-6. A crucial question is how the relationship between black holes and galaxies evolves with time; a key epoch to examine this relationship is at the peaks of star formation and black hole growth 8-12 billion years ago (redshifts 1-3)7. Here we report a dynamical measurement of the mass of the black hole in a luminous quasar at a redshift of 2, with a look back in time of 11 billion years, by spatially resolving the broad-line region (BLR). We detect a 40-μas (0.31-pc) spatial offset between the red and blue photocentres of the Hα line that traces the velocity gradient of a rotating BLR. The flux and differential phase spectra are well reproduced by a thick, moderately inclined disk of gas clouds within the sphere of influence of a central black hole with a mass of 3.2 × 108 solar masses. Molecular gas data reveal a dynamical mass for the host galaxy of 6 × 1011 solar masses, which indicates an undermassive black hole accreting at a super-Eddington rate. This suggests a host galaxy that grew faster than the SMBH, indicating a delay between galaxy and black hole formation for some systems.
Collapse
Affiliation(s)
- R Abuter
- European Southern Observatory, Garching, Germany
| | - F Allouche
- Université Côte d'Azur, Observatoire de la Côte d'Azur, CNRS, Laboratoire Lagrange, Nice, France
| | - A Amorim
- Faculdade de Ciências, Universidade de Lisboa, Lisboa, Portugal
- CENTRA - Centro de Astrofísica e Gravitação, Instituto Superior Técnico (IST), Universidade de Lisboa, Lisboa, Portugal
| | - C Bailet
- Université Côte d'Azur, Observatoire de la Côte d'Azur, CNRS, Laboratoire Lagrange, Nice, France
| | - A Berdeu
- LESIA - Observatoire de Paris, Université PSL, Sorbonne Université, Université Paris Cité, CNRS, Meudon, France
| | - J-P Berger
- Université Grenoble Alpes, CNRS, IPAG, Grenoble, France
| | - P Berio
- Université Côte d'Azur, Observatoire de la Côte d'Azur, CNRS, Laboratoire Lagrange, Nice, France
| | - A Bigioli
- Institute of Astronomy, KU Leuven, Leuven, Belgium
| | - O Boebion
- Université Côte d'Azur, Observatoire de la Côte d'Azur, CNRS, Laboratoire Lagrange, Nice, France
| | - M-L Bolzer
- Max Planck Institute for Extraterrestrial Physics, Garching, Germany
- Department of Physics, Technical University Munich, Garching, Germany
- Univ. Lyon, Univ. Lyon 1, ENS de Lyon, CNRS, Centre de Recherche Astrophysique de Lyon UMR5574, Saint-Genis-Laval, France
| | - H Bonnet
- European Southern Observatory, Garching, Germany
| | - G Bourdarot
- Max Planck Institute for Extraterrestrial Physics, Garching, Germany
| | - P Bourget
- European Southern Observatory, Santiago, Chile
| | - W Brandner
- Max Planck Institute for Astronomy, Heidelberg, Germany
| | - Y Cao
- Max Planck Institute for Extraterrestrial Physics, Garching, Germany
| | - R Conzelmann
- European Southern Observatory, Garching, Germany
| | - M Comin
- European Southern Observatory, Garching, Germany
| | - Y Clénet
- LESIA - Observatoire de Paris, Université PSL, Sorbonne Université, Université Paris Cité, CNRS, Meudon, France
| | - B Courtney-Barrer
- European Southern Observatory, Santiago, Chile
- Research School of Astronomy and Astrophysics, College of Science, Australian National University, Canberra, Australian Capital Territory, Australia
| | - R Davies
- Max Planck Institute for Extraterrestrial Physics, Garching, Germany
| | - D Defrère
- Institute of Astronomy, KU Leuven, Leuven, Belgium
| | - A Delboulbé
- Université Grenoble Alpes, CNRS, IPAG, Grenoble, France
| | | | - R Dembet
- LESIA - Observatoire de Paris, Université PSL, Sorbonne Université, Université Paris Cité, CNRS, Meudon, France
| | - J Dexter
- Department of Astrophysical & Planetary Sciences, JILA, University of Colorado Boulder, Boulder, CO, USA
| | | | - A Drescher
- Max Planck Institute for Extraterrestrial Physics, Garching, Germany
| | - A Eckart
- Max Planck Institute for Radio Astronomy, Bonn, Germany
- 1st Institute of Physics, University of Cologne, Cologne, Germany
| | - C Édouard
- LESIA - Observatoire de Paris, Université PSL, Sorbonne Université, Université Paris Cité, CNRS, Meudon, France
| | - F Eisenhauer
- Max Planck Institute for Extraterrestrial Physics, Garching, Germany
| | - M Fabricius
- Max Planck Institute for Extraterrestrial Physics, Garching, Germany
| | - H Feuchtgruber
- Max Planck Institute for Extraterrestrial Physics, Garching, Germany
| | - G Finger
- Max Planck Institute for Extraterrestrial Physics, Garching, Germany
| | | | - P Garcia
- CENTRA - Centro de Astrofísica e Gravitação, Instituto Superior Técnico (IST), Universidade de Lisboa, Lisboa, Portugal
- Faculdade de Engenharia, Universidade do Porto, Porto, Portugal
| | - R Garcia Lopez
- School of Physics, University College Dublin, Belfield, Dublin 4, Ireland
| | - F Gao
- Max Planck Institute for Radio Astronomy, Bonn, Germany
| | - E Gendron
- LESIA - Observatoire de Paris, Université PSL, Sorbonne Université, Université Paris Cité, CNRS, Meudon, France
| | - R Genzel
- Max Planck Institute for Extraterrestrial Physics, Garching, Germany
- Departments of Physics, University of California, Berkeley, Berkeley, CA, USA
- Department of Astronomy, University of California, Berkeley, Berkeley, CA, USA
| | - J P Gil
- European Southern Observatory, Santiago, Chile
| | - S Gillessen
- Max Planck Institute for Extraterrestrial Physics, Garching, Germany
| | - T Gomes
- CENTRA - Centro de Astrofísica e Gravitação, Instituto Superior Técnico (IST), Universidade de Lisboa, Lisboa, Portugal
- Faculdade de Engenharia, Universidade do Porto, Porto, Portugal
| | - F Gonté
- European Southern Observatory, Garching, Germany
| | - C Gouvret
- Université Côte d'Azur, Observatoire de la Côte d'Azur, CNRS, Laboratoire Lagrange, Nice, France
| | - P Guajardo
- European Southern Observatory, Santiago, Chile
| | - S Guieu
- Université Grenoble Alpes, CNRS, IPAG, Grenoble, France
| | - W Hackenberg
- European Southern Observatory, Garching, Germany
| | - N Haddad
- European Southern Observatory, Santiago, Chile
| | - M Hartl
- Max Planck Institute for Extraterrestrial Physics, Garching, Germany
| | - X Haubois
- European Southern Observatory, Santiago, Chile
| | - F Haußmann
- Max Planck Institute for Extraterrestrial Physics, Garching, Germany
| | - G Heißel
- LESIA - Observatoire de Paris, Université PSL, Sorbonne Université, Université Paris Cité, CNRS, Meudon, France
- Advanced Concepts Team, European Space Agency, TEC-SF, ESTEC, Noordwijk, The Netherlands
| | - Th Henning
- Max Planck Institute for Astronomy, Heidelberg, Germany
| | - S Hippler
- Max Planck Institute for Astronomy, Heidelberg, Germany
| | - S F Hönig
- School of Physics and Astronomy, University of Southampton, Southampton, UK
| | - M Horrobin
- 1st Institute of Physics, University of Cologne, Cologne, Germany
| | - N Hubin
- European Southern Observatory, Garching, Germany
| | - E Jacqmart
- Université Côte d'Azur, Observatoire de la Côte d'Azur, CNRS, Laboratoire Lagrange, Nice, France
| | - L Jocou
- Université Grenoble Alpes, CNRS, IPAG, Grenoble, France
| | - A Kaufer
- European Southern Observatory, Santiago, Chile
| | - P Kervella
- LESIA - Observatoire de Paris, Université PSL, Sorbonne Université, Université Paris Cité, CNRS, Meudon, France
| | - J Kolb
- European Southern Observatory, Garching, Germany
| | - H Korhonen
- European Southern Observatory, Santiago, Chile
- Max Planck Institute for Astronomy, Heidelberg, Germany
| | - S Lacour
- European Southern Observatory, Garching, Germany
- LESIA - Observatoire de Paris, Université PSL, Sorbonne Université, Université Paris Cité, CNRS, Meudon, France
| | - S Lagarde
- Université Côte d'Azur, Observatoire de la Côte d'Azur, CNRS, Laboratoire Lagrange, Nice, France
| | - O Lai
- Université Côte d'Azur, Observatoire de la Côte d'Azur, CNRS, Laboratoire Lagrange, Nice, France
| | - V Lapeyrère
- LESIA - Observatoire de Paris, Université PSL, Sorbonne Université, Université Paris Cité, CNRS, Meudon, France
| | - R Laugier
- Institute of Astronomy, KU Leuven, Leuven, Belgium
| | | | - J Leftley
- Université Côte d'Azur, Observatoire de la Côte d'Azur, CNRS, Laboratoire Lagrange, Nice, France
| | - P Léna
- LESIA - Observatoire de Paris, Université PSL, Sorbonne Université, Université Paris Cité, CNRS, Meudon, France
| | - S Lewis
- European Southern Observatory, Garching, Germany
| | - D Liu
- Max Planck Institute for Extraterrestrial Physics, Garching, Germany
| | - B Lopez
- Université Côte d'Azur, Observatoire de la Côte d'Azur, CNRS, Laboratoire Lagrange, Nice, France
| | - D Lutz
- Max Planck Institute for Extraterrestrial Physics, Garching, Germany
| | - Y Magnard
- Université Grenoble Alpes, CNRS, IPAG, Grenoble, France
| | - F Mang
- Max Planck Institute for Extraterrestrial Physics, Garching, Germany
- Department of Physics, Technical University Munich, Garching, Germany
| | - A Marcotto
- Université Côte d'Azur, Observatoire de la Côte d'Azur, CNRS, Laboratoire Lagrange, Nice, France
| | - D Maurel
- Université Grenoble Alpes, CNRS, IPAG, Grenoble, France
| | - A Mérand
- European Southern Observatory, Garching, Germany
| | - F Millour
- Université Côte d'Azur, Observatoire de la Côte d'Azur, CNRS, Laboratoire Lagrange, Nice, France
| | - N More
- Max Planck Institute for Extraterrestrial Physics, Garching, Germany
| | - H Netzer
- School of Physics and Astronomy, Tel Aviv University, Tel Aviv, Israel
| | - H Nowacki
- Université Grenoble Alpes, CNRS, IPAG, Grenoble, France
| | - M Nowak
- Institute of Astronomy, University of Cambridge, Cambridge, UK
| | - S Oberti
- European Southern Observatory, Garching, Germany
| | - T Ott
- Max Planck Institute for Extraterrestrial Physics, Garching, Germany
| | - L Pallanca
- European Southern Observatory, Santiago, Chile
| | - T Paumard
- LESIA - Observatoire de Paris, Université PSL, Sorbonne Université, Université Paris Cité, CNRS, Meudon, France
| | - K Perraut
- Université Grenoble Alpes, CNRS, IPAG, Grenoble, France
| | - G Perrin
- LESIA - Observatoire de Paris, Université PSL, Sorbonne Université, Université Paris Cité, CNRS, Meudon, France
| | - R Petrov
- Université Côte d'Azur, Observatoire de la Côte d'Azur, CNRS, Laboratoire Lagrange, Nice, France
| | - O Pfuhl
- European Southern Observatory, Garching, Germany
| | - N Pourré
- Université Grenoble Alpes, CNRS, IPAG, Grenoble, France
| | - S Rabien
- Max Planck Institute for Extraterrestrial Physics, Garching, Germany
| | - C Rau
- Max Planck Institute for Extraterrestrial Physics, Garching, Germany
| | - M Riquelme
- European Southern Observatory, Garching, Germany
| | - S Robbe-Dubois
- Université Côte d'Azur, Observatoire de la Côte d'Azur, CNRS, Laboratoire Lagrange, Nice, France
| | - S Rochat
- Université Grenoble Alpes, CNRS, IPAG, Grenoble, France
| | - M Salman
- Institute of Astronomy, KU Leuven, Leuven, Belgium
| | - J Sanchez-Bermudez
- Max Planck Institute for Astronomy, Heidelberg, Germany
- Instituto de Astronomía, Universidad Nacional Autónoma de México, Ciudad de México, Mexico
| | - D J D Santos
- Max Planck Institute for Extraterrestrial Physics, Garching, Germany
| | - S Scheithauer
- Max Planck Institute for Astronomy, Heidelberg, Germany
| | - M Schöller
- European Southern Observatory, Garching, Germany
| | - J Schubert
- Max Planck Institute for Extraterrestrial Physics, Garching, Germany
| | - N Schuhler
- European Southern Observatory, Santiago, Chile
| | - J Shangguan
- Max Planck Institute for Extraterrestrial Physics, Garching, Germany
| | | | - T T Shimizu
- Max Planck Institute for Extraterrestrial Physics, Garching, Germany.
| | - A Sevin
- LESIA - Observatoire de Paris, Université PSL, Sorbonne Université, Université Paris Cité, CNRS, Meudon, France
| | - F Soulez
- Univ. Lyon, Univ. Lyon 1, ENS de Lyon, CNRS, Centre de Recherche Astrophysique de Lyon UMR5574, Saint-Genis-Laval, France
| | - A Spang
- Université Côte d'Azur, Observatoire de la Côte d'Azur, CNRS, Laboratoire Lagrange, Nice, France
| | - E Stadler
- Université Grenoble Alpes, CNRS, IPAG, Grenoble, France
| | - A Sternberg
- School of Physics and Astronomy, Tel Aviv University, Tel Aviv, Israel
- Center for Computational Astrophysics, Flatiron Institute, New York, NY, USA
| | - C Straubmeier
- 1st Institute of Physics, University of Cologne, Cologne, Germany
| | - E Sturm
- Max Planck Institute for Extraterrestrial Physics, Garching, Germany
| | - C Sykes
- School of Physics and Astronomy, University of Southampton, Southampton, UK
| | - L J Tacconi
- Max Planck Institute for Extraterrestrial Physics, Garching, Germany
| | | | - F Vincent
- LESIA - Observatoire de Paris, Université PSL, Sorbonne Université, Université Paris Cité, CNRS, Meudon, France
| | | | - S Uysal
- Max Planck Institute for Extraterrestrial Physics, Garching, Germany
| | - F Widmann
- Max Planck Institute for Extraterrestrial Physics, Garching, Germany
| | - E Wieprecht
- Max Planck Institute for Extraterrestrial Physics, Garching, Germany
| | - E Wiezorrek
- Max Planck Institute for Extraterrestrial Physics, Garching, Germany
| | - J Woillez
- European Southern Observatory, Garching, Germany
| | - G Zins
- European Southern Observatory, Garching, Germany
| |
Collapse
|
2
|
Brooks SJ, Gomes T, Grung M, Petersen K, Macken A. An integrated biological effects assessment of the discharge water into the Sunndalsfjord from an aluminium smelter. Sci Total Environ 2023; 904:166798. [PMID: 37673263 DOI: 10.1016/j.scitotenv.2023.166798] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/05/2023] [Revised: 08/14/2023] [Accepted: 09/01/2023] [Indexed: 09/08/2023]
Abstract
An integrated biological effects study using field transplanted mussels was applied to determine the potential biological effects of an effluent discharge from an aluminium smelter into a Norwegian fjord. Chemical body burden and biological effects were measured in mussels positioned downstream (1, 2, 5, 10 and 20 km) from the aluminium smelters discharge for a period of 6 weeks. A suite of biomarkers, from whole organism to subcellular responses were measured. Chemical concentrations in mussel tissues were low; however, a change in the PAC (polyaromatic compound) profile from high to low pyrogenic influence provided evidence of exposure to the smelter's effluent. Overall, the biological responses observed where greater in the mussels positioned closest to the smelter (1-5 km). Lowest chemical accumulation and biomarker responses were observed in mussels positioned 10 km from the smelter and were considered as the reference field population. Mussels located furthest from the smelter (20 km) exhibited significant biomarker responses and suggested a different contaminant source within the fjord. The integrated biological response index (IBR) was applied and reflected the expected level of exposure to the smelters discharge, with highest IBR calculated in mussels positioned closest to the discharge (1-5 km). Principal component analysis (PCA) also differentiated among mussel groups, with the most impacted located closest to the smelter. Not one chemical factor could explain the biological responses observed in mussels, but the presence of PAH16, PAH41 and metals Mn, Ni and Cr were the main contributors measured to the higher stress seen in the mussels from the 1 and 5 km groups.
Collapse
Affiliation(s)
- S J Brooks
- Norwegian Institute for Water Research (NIVA), Økernveien 94, 0579 Oslo, Norway.
| | - T Gomes
- Norwegian Institute for Water Research (NIVA), Økernveien 94, 0579 Oslo, Norway
| | - M Grung
- Norwegian Institute for Water Research (NIVA), Økernveien 94, 0579 Oslo, Norway
| | - K Petersen
- Norwegian Institute for Water Research (NIVA), Økernveien 94, 0579 Oslo, Norway
| | - A Macken
- Norwegian Institute for Water Research (NIVA), Økernveien 94, 0579 Oslo, Norway
| |
Collapse
|
3
|
Gomes T, Ribeiro PS, Carvalho NB, El-Hani CN, Figueira CP, Ristow P. Impact of Extracellular DNA on Architectural Parameters of Leptospira biflexa Biofilm. Indian J Microbiol 2023; 63:373-379. [PMID: 37781014 PMCID: PMC10533471 DOI: 10.1007/s12088-023-01085-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2023] [Accepted: 07/22/2023] [Indexed: 10/03/2023] Open
Abstract
Extracellular DNA (eDNA) is a major component of bacterial biofilms. In this study, we performed a three-dimensional analysis of Leptospira biofilm using advanced imaging by confocal laser scanning microscopy (CLSM) and multi-parameter analysis by COMSTAT 2 software, with quantification of Leptospira and eDNA fluorescence. To investigate the role of eDNA in Leptospira biofilm, we treated Leptospira biflexa biofilms with DNase I enzyme (DNase), which digested eDNA, and compared DNase treated biofilms and controls. There was a significant reduction of the biomass of biofilms treated with DNase, by spectrophotometry and COMSTAT analysis. The multiparameter analysis evidenced for DNase-treated biofilms a significant decrease in the surface area and the average thickness; opposing to a significant augmentation of the surface/biovolume ratio and the roughness coefficient (Ra*), when compared to controls. We analyzed the parameters of DNase-treated biofilms by Pearson's correlation coefficient and found significant positive correlations between biomass and average thickness; biomass and surface area; surface area and average thickness. On the other hand, there were significant negative correlations between Ra* and biomass; Ra* and average thickness; Ra* and surface area. These findings suggest that eDNA digestion results in biofilm instability and alteration of the three-dimensional architecture, justifying the negative correlation between Ra* and the above-mentioned parameters. In conclusion, our study showed that eDNA digestion produced a massive structural loss, instability, and dramatic changes in the three-dimensional architecture of Leptospira biflexa biofilm. These findings contribute to a better understanding of the role of eDNA and highlight the importance of eDNA as a key component in Leptospira biofilms.
Collapse
Affiliation(s)
- T. Gomes
- Institute of Biology, Federal University of Bahia, Salvador, Bahia 40170-115 Brazil
- Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais 31270-901 Brazil
- National Institute of Science and Technology in Interdisciplinary and Transdisciplinary Studies in Ecology and Evolution (INCT IN-TREE), Institute of Biology, Federal University of Bahia, Salvador, Bahia 40170-115 Brazil
| | - P. S. Ribeiro
- Institute of Biology, Federal University of Bahia, Salvador, Bahia 40170-115 Brazil
- Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais 31270-901 Brazil
- National Institute of Science and Technology in Interdisciplinary and Transdisciplinary Studies in Ecology and Evolution (INCT IN-TREE), Institute of Biology, Federal University of Bahia, Salvador, Bahia 40170-115 Brazil
| | - N. B. Carvalho
- Institute of Biology, Federal University of Bahia, Salvador, Bahia 40170-115 Brazil
- National Institute of Science and Technology in Interdisciplinary and Transdisciplinary Studies in Ecology and Evolution (INCT IN-TREE), Institute of Biology, Federal University of Bahia, Salvador, Bahia 40170-115 Brazil
| | - C. N. El-Hani
- Institute of Biology, Federal University of Bahia, Salvador, Bahia 40170-115 Brazil
- National Institute of Science and Technology in Interdisciplinary and Transdisciplinary Studies in Ecology and Evolution (INCT IN-TREE), Institute of Biology, Federal University of Bahia, Salvador, Bahia 40170-115 Brazil
| | - C. P. Figueira
- Gonçalo Moniz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Salvador, Bahia 40296-710 Brazil
| | - P. Ristow
- Institute of Biology, Federal University of Bahia, Salvador, Bahia 40170-115 Brazil
- National Institute of Science and Technology in Interdisciplinary and Transdisciplinary Studies in Ecology and Evolution (INCT IN-TREE), Institute of Biology, Federal University of Bahia, Salvador, Bahia 40170-115 Brazil
- Gonçalo Moniz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Salvador, Bahia 40296-710 Brazil
| |
Collapse
|
4
|
Conde M, Costa AS, Gomes T. Benign metastasizing leiomyoma presenting as multiple pulmonary nodules: A radiological-pathological correlation. Pulmonology 2023; 29:160-162. [PMID: 36371395 DOI: 10.1016/j.pulmoe.2022.10.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2022] [Revised: 10/18/2022] [Accepted: 10/19/2022] [Indexed: 11/11/2022] Open
Affiliation(s)
- M Conde
- Pulmonology Department, Centro Hospitalar de Trás-os-Montes e Alto Douro, Vila Real, Portugal.
| | - A S Costa
- Radiology Department, Hospital Prof. Doutor Fernando Fonseca, E.P.E, Portugal
| | - T Gomes
- Pulmonology Department, Centro Hospitalar de Trás-os-Montes e Alto Douro, Vila Real Portugal
| |
Collapse
|
5
|
Domínguez Conde C, Xu C, Jarvis LB, Rainbow DB, Wells SB, Gomes T, Howlett SK, Suchanek O, Polanski K, King HW, Mamanova L, Huang N, Szabo PA, Richardson L, Bolt L, Fasouli ES, Mahbubani KT, Prete M, Tuck L, Richoz N, Tuong ZK, Campos L, Mousa HS, Needham EJ, Pritchard S, Li T, Elmentaite R, Park J, Rahmani E, Chen D, Menon DK, Bayraktar OA, James LK, Meyer KB, Yosef N, Clatworthy MR, Sims PA, Farber DL, Saeb-Parsy K, Jones JL, Teichmann SA. Cross-tissue immune cell analysis reveals tissue-specific features in humans. Science 2022; 376:eabl5197. [PMID: 35549406 PMCID: PMC7612735 DOI: 10.1126/science.abl5197] [Citation(s) in RCA: 191] [Impact Index Per Article: 95.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Despite their crucial role in health and disease, our knowledge of immune cells within human tissues remains limited. We surveyed the immune compartment of 16 tissues from 12 adult donors by single-cell RNA sequencing and VDJ sequencing generating a dataset of ~360,000 cells. To systematically resolve immune cell heterogeneity across tissues, we developed CellTypist, a machine learning tool for rapid and precise cell type annotation. Using this approach, combined with detailed curation, we determined the tissue distribution of finely phenotyped immune cell types, revealing hitherto unappreciated tissue-specific features and clonal architecture of T and B cells. Our multitissue approach lays the foundation for identifying highly resolved immune cell types by leveraging a common reference dataset, tissue-integrated expression analysis, and antigen receptor sequencing.
Collapse
Affiliation(s)
- C Domínguez Conde
- Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK
| | - C Xu
- Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK
| | - LB Jarvis
- Department of Clinical Neurosciences, University of Cambridge
| | - DB Rainbow
- Department of Clinical Neurosciences, University of Cambridge
| | - SB Wells
- Department of Systems Biology, Columbia University Irving Medical Center
| | - T Gomes
- Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK
| | - SK Howlett
- Department of Clinical Neurosciences, University of Cambridge
| | - O Suchanek
- Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, UK
| | - K Polanski
- Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK
| | - HW King
- Centre for Immunobiology, Blizard Institute, Queen Mary University of London, London, UK
| | - L Mamanova
- Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK
| | - N Huang
- Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK
| | - PA Szabo
- Department of Microbiology and Immunology, Columbia University Irving Medical Center
| | - L Richardson
- Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK
| | - L Bolt
- Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK
| | - ES Fasouli
- Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK
| | - KT Mahbubani
- Department of Surgery, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Cambridge, UK
| | - M Prete
- Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK
| | - L Tuck
- Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK
| | - N Richoz
- Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, UK
| | - ZK Tuong
- Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK
- Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, UK
| | - L Campos
- Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK
- West Suffolk Hospital NHS Trust, Bury Saint Edmunds, UK
| | - HS Mousa
- Department of Clinical Neurosciences, University of Cambridge
| | - EJ Needham
- Department of Clinical Neurosciences, University of Cambridge
| | - S Pritchard
- Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK
| | - T Li
- Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK
| | - R Elmentaite
- Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK
| | - J Park
- Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK
| | - E Rahmani
- Center for Computational Biology, University of California, Berkeley, Berkeley, CA, USA
- Department of Electrical Engineering and Computer Sciences, University of California, Berkeley, Berkeley, CA, USA
| | - D Chen
- Department of Systems Biology, Columbia University Irving Medical Center
| | - DK Menon
- Department of Anaesthesia, University of Cambridge, Cambridge, UK
| | - OA Bayraktar
- Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK
| | - LK James
- Centre for Immunobiology, Blizard Institute, Queen Mary University of London, London, UK
| | - KB Meyer
- Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK
| | - N Yosef
- Center for Computational Biology, University of California, Berkeley, Berkeley, CA, USA
- Department of Electrical Engineering and Computer Sciences, University of California, Berkeley, Berkeley, CA, USA
- Chan Zuckerberg Biohub, San Francisco, CA, USA
- Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
| | - MR Clatworthy
- Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK
- Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, UK
| | - PA Sims
- Department of Systems Biology, Columbia University Irving Medical Center
| | - DL Farber
- Department of Microbiology and Immunology, Columbia University Irving Medical Center
| | - K Saeb-Parsy
- Department of Surgery, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Cambridge, UK
| | - JL Jones
- Department of Clinical Neurosciences, University of Cambridge
| | - SA Teichmann
- Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK
- Theory of Condensed Matter, Cavendish Laboratory, Department of Physics, University of Cambridge, JJ Thomson Ave, Cambridge CB3 0HE, UK
| |
Collapse
|
6
|
Rudoler D, Kurdyak P, Gomes T, Huang A, Jones W, Littleford S, Paracha N, Fischer B. Evaluating the population-level effects of oxycodone restrictions on prescription opioid utilization in Ontario. Pharmacoepidemiol Drug Saf 2022; 31:769-778. [PMID: 35470515 DOI: 10.1002/pds.5442] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2021] [Revised: 03/11/2022] [Accepted: 04/12/2022] [Indexed: 11/07/2022]
Abstract
PURPOSE To investigate the impact of restrictions on access to long acting oxycodone on prescription opioid use and opioid-related harms. METHODS Administrative health data from Ontario, Canada was used to measure differences in opioids dispensed and ED visits for opioid-related overdose, poisoning or substance use following provincial restrictions on access to publicly insured OxyContin (February 29, 2012) and OxyNeo (February 28, 2013). This study focused on the cohort of provincial drug insurance eligible people (people 65+ and select low-income populations) who were dispensed oxycodone prior to the restrictions. Difference-in-differences models with a propensity score matched comparison group of people who were dispensed non-oxycodone opioids were used to estimate the main effects. RESULTS In the six months following the delisting of OxyContin, MMEs per person per week for all opioids fell by an average of 7.5% in people dispensed oxycodone relative to the comparison group, and an average of 13.8% in chronic recipients of oxycodone. In the six months following the restrictions on OxyNeo, MMEs per person per week fell by an average of 3.1% in all people dispensed oxycodone, and 25.2% in chronic oxycodone recipients. The decline in oxycodone dispensing amongst chronic oxycodone recipients corresponded with an increase in dispensing of other opioid formulations, particularly hydromorphone and fentanyl. No important differences were observed for ED visits related to opioid poisoning, overdose, or substance use disorder. CONCLUSIONS Province-wide restrictions on access to long acting oxycodone had an impact on quantities of all opioids dispensed to chronic recipients of oxycodone, but small impacts on the full population of people dispensed oxycodone; the decline in use was partially offset by increases in use of other publicly-funded opioid formulations. This study suggests that policies limiting access to specific prescription opioids led to overall reductions in publicly-funded prescription opioid use, particularly in chronic oxycodone recipients, without immediate evidence of changes in opioid-related ED visits. This article is protected by copyright. All rights reserved.
Collapse
Affiliation(s)
- D Rudoler
- Ontario Shores Centre for Mental Health Sciences, Whitby, Ontario, Canada.,Faculty of Health Sciences, Ontario Tech University, Oshawa, Ontario, Canada.,ICES, Toronto, Ontario, Canada.,Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
| | - P Kurdyak
- ICES, Toronto, Ontario, Canada.,Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.,Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - T Gomes
- ICES, Toronto, Ontario, Canada.,Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.,Leslie Dan Faculty of Pharmacy, University of Toronto, Ontario, Canada.,Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada
| | - A Huang
- ICES, Toronto, Ontario, Canada
| | - W Jones
- Centre for Applied Research in Mental Health and Addiction (CARMHA), Faculty of Health Sciences, Simon Fraser University, Suite 2400 515 W. Hastings Street, Vancouver, British Columbia, Canada
| | - S Littleford
- Faculty of Health Sciences, Ontario Tech University, Oshawa, Ontario, Canada
| | - N Paracha
- Faculty of Health Sciences, Ontario Tech University, Oshawa, Ontario, Canada
| | - B Fischer
- Faculty of Medical and Health Sciences, University of Auckland, 85 Park Rd, Grafton, Auckland, New Zealand.,Centre for Applied Research in Mental Health and Addiction (CARMHA), Faculty of Health Sciences, Simon Fraser University, Suite 2400 515 W. Hastings Street, Vancouver, British Columbia, Canada.,Department of Psychiatry, University of Toronto, 250 College Street 8th floor, Toronto, Ontario, Canada.,Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil
| |
Collapse
|
7
|
Alves F, Calado R, Relvas M, Gomes T, Gonçalo M. Short courses of ciclosporin can induce long remissions in chronic spontaneous urticaria. J Eur Acad Dermatol Venereol 2022; 36:e645-e646. [PMID: 35344624 DOI: 10.1111/jdv.18107] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2021] [Revised: 12/20/2021] [Accepted: 01/18/2022] [Indexed: 11/30/2022]
Affiliation(s)
- F Alves
- Dermatology Department, Coimbra Hospital and University Center
| | - R Calado
- Dermatology Department, Coimbra Hospital and University Center
| | - M Relvas
- Dermatology Department, Coimbra Hospital and University Center
| | - T Gomes
- Dermatology Department, Leiria Hospital
| | - M Gonçalo
- Dermatology Department, Coimbra Hospital and University Center.,Faculty of Medicine, University of Coimbra
| |
Collapse
|
8
|
Kuenzig E, Mason J, Bernstein CN, Gomes T, Juurlink D, Kaplan GG, Peña-Sánchez J, Targownik LE, Vigod S, Begum J, Nugent Z, Benchimol EI. A159 OPIOID USE IS DECLINING AMONG PEOPLE WITH INFLAMMATORY BOWEL DISEASE: A POPULATION-BASED STUDY. J Can Assoc Gastroenterol 2022. [PMCID: PMC8859290 DOI: 10.1093/jcag/gwab049.158] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Background Patients with inflammatory bowel disease (IBD) are more likely to use opioids than those without IBD and are more susceptible to the negative consequences of opioid use, including increased risk of death. Aims Examine trends in the use of opioids among people with and without IBD, where opioids were prescribed, and who prescribed them. Methods We identified Ontarians with IBD (7/2012–3/2017) from population-based health administrative data using validated algorithms. We matched each patient with IBD on age and sex to 5 people without IBD. We calculated age- and sex-standardized quarterly rates of patients taking opioids, characterized as any, chronic (>90 days), or acute (≤90 days) among people with and without IBD. Among people with IBD, we identified the location of the last healthcare interaction prior to filling the prescription (hospital, emergency department [ED], outpatient clinic), presuming this was where the opioid was prescribed. Opioids prescribed after outpatient visits were stratified by specialty (gastroenterologist, family physician/internist, surgeon, other). Average quarterly percentage change was calculated using Poisson regression, adjusting for age, sex, income, and rural/urban household. Results Of 92,233 IBD patients (mean 47 y at study entry, 45% male, 50% Crohn’s), 56% had at least 1 opioid prescription during the study period. Opioid use was more common among people with IBD (any: IRR 2.11, 95% CI 2.08–2.14; chronic: IRR 2.61, 95% CI 2.54–2.69; acute: IRR 1.82, 95% CI 1.79–1.94), Figure A. Among IBD patients, any opioid use decreased by 0.5% (95%CI 0.4–0.5) per quarter, from 13.4% (95%CI 13.1–13.6) to 12.7% (95%CI 12.5–13.0). Chronic opioid use decreased by 0.3% (95%CI 0.2–0.4) per quarter while acute opioid use among IBD patients decreased by 0.6% (95% CI 0.5–0.7) per quarter. Most opioids were prescribed after an outpatient visit (70.2%), most often (82.7%) by a family physician or internist. Total outpatient prescriptions declined by 1.9% (95%CI 1.7–2.0) per quarter, from 5.8% (95%CI 5.6–5.9) to 3.8% (95%CI 3.7–3.9). Relative quarterly decreases were similar across all specialties, Figure B. Conclusions Opioid use remains common among IBD patients but has decreased since 2012. The prescriptions most often originated after outpatient visits to family physicians and internists rather than gastroenterologists or surgeons. ![]()
Trends in (A) the acute and chronic opioid use among those with and without IBD and (B) the specialist prescribing opioids to IBD patients when the most recent healthcare contact was an outpatient visit. Funding Agencies American College of Gastroenterology
Collapse
Affiliation(s)
- E Kuenzig
- Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Department of Pediatrics, University of Toronto, Toronto, ON, Canada
| | - J Mason
- Centre for Addiction and Mental Health, Toronto, ON, Canada
| | | | - T Gomes
- University of Toronto, Toronto, ON, Canada
| | - D Juurlink
- University of Toronto, Toronto, ON, Canada
| | - G G Kaplan
- Medicine and Community Health Sciences, University of Calgary, Calgary, AB, Canada
| | - J Peña-Sánchez
- Department of Community Health and Epidemiology, University of Saskatchewan, Saskatoon, SK, Canada
| | | | - S Vigod
- Women’s College Hospital, Toronto, ON, Canada
| | | | - Z Nugent
- University of Manitoba, Winnipeg, MB, Canada
| | - E I Benchimol
- Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Department of Pediatrics, University of Toronto, Toronto, ON, Canada
| |
Collapse
|
9
|
Kuenzig E, Mason J, Bernstein CN, Gomes T, Juurlink D, Kaplan GG, Peña-Sánchez J, Targownik LE, Vigod S, Begum J, Nugent Z, Benchimol EI. A162 CHRONIC OPIOID THERAPY IS ASSOCIATED WITH INCREASED HEALTH SERVICES UTILIZATION AND DIRECT HEALTHCARE COSTS: A POPULATION-BASED STUDY. J Can Assoc Gastroenterol 2022. [PMCID: PMC8859354 DOI: 10.1093/jcag/gwab049.161] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Background Opioid use is more common among people living with Inflammatory bowel disease (IBD). Aims Investigate the associations between receiving chronic opioid therapy and health services utilization and direct healthcare costs among IBD patients receiving chronic opioid therapy. Methods We identified prevalent cases of IBD in Ontario (7/2012–3/2017) from population-based health administrative data using previously validated algorithms. Patients with ongoing opioid use for >90 days (chronic opioid recipients) were matched based on age, sex, IBD type, and disease duration with up to 5 IBD patients with no period of chronic opioid use. For the year after becoming a chronic opioid recipient (i.e., from the 91st day of chronic opioid therapy), we determined: 1) the mean (SD) number of IBD-specific, IBD-related, and all-cause outpatient visits, emergency department (ED) visits, and hospitalizations; and 2) total, hospitalization, ED, and outpatient healthcare costs. IBD-specific visits had a diagnostic code for Crohn’s disease or ulcerative colitis; IBD-related visits additionally included diagnostic codes for signs, symptoms, and extra-intestinal manifestations of IBD. Patients were censored at the time of a new cancer diagnosis or upon initiation of palliative care. We used Poisson models to compare the number of healthcare encounters in chronic opioid recipients and patients with no period of chronic opioid therapy then used generalized linear models with a gamma distribution and log-link to compare direct healthcare costs in the two groups. Regression models accounted for matching and were adjusted for income, rural/urban household, and comorbidities (resource intensity using the John Hopkins ACG Index). Results We identified 9913 IBD patients with at least one period of chronic opioid therapy matched to 44,274 without chronic opioid therapy (mean 43 y at chronic opioid use, 43% male, 58% Crohn’s). Patients receiving chronic opioid therapy had significantly more health care encounters (Figure A). Annual per capita total health care cost among chronic opioid recipients was $13,452 (SD 33,777) compared to $5140 (SD 28,999) among patients with no chronic opioid therapy (Figure B). After adjustment, healthcare costs were approximately double in chronic opioid recipients and was consistent for all cost types (overall, hospitalization, ED, and outpatient). Conclusions IBD patients who were chronic opioid users had significantly more health services utilization and direct healthcare costs compared to patients without periods of chronic opioid use. These associations persisted after adjusting for the resource intensity of any co-occurring conditions. ![]()
Health services utilization (A) and direct healthcare costs (B) among people with inflammatory bowel disease (IBD) who are chronic opioid users compared to those without a period of chronic opioid use. Funding Agencies American College of Gastroenterology
Collapse
Affiliation(s)
- E Kuenzig
- Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Department of Pediatrics, University of Toronto, Toronto, ON, Canada
| | - J Mason
- Centre for Addiction and Mental Health, Toronto, ON, Canada
| | | | - T Gomes
- University of Toronto, Toronto, ON, Canada
| | - D Juurlink
- University of Toronto, Toronto, ON, Canada
| | - G G Kaplan
- Medicine and Community Health Sciences, University of Calgary, Calgary, AB, Canada
| | - J Peña-Sánchez
- Department of Community Health and Epidemiology, University of Saskatchewan, Saskatoon, SK, Canada
| | | | - S Vigod
- Women’s College Hospital, Toronto, ON, Canada
| | | | - Z Nugent
- Internal Medicine, University of Manitoba, Winnipeg, MB, Canada
| | - E I Benchimol
- Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Department of Pediatrics, University of Toronto, Toronto, ON, Canada
| |
Collapse
|
10
|
Cheung DC, Martin LJ, Jivraj NK, Clarke H, Gomes T, Wijeysundera DN, Diong C, Nayan M, Saarela O, Alibhai S, Komisarenko M, Fleshner NE, Kulkarni GS, Finelli A. Opioid Use after Nephrectomy for Kidney Cancer in Ontario: A Population-Based Study. Urology 2022; 164:118-123. [PMID: 35182588 DOI: 10.1016/j.urology.2022.02.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2021] [Revised: 01/09/2022] [Accepted: 02/03/2022] [Indexed: 12/26/2022]
Abstract
OBJECTIVE To compare the odds of early and prolonged post-operative opioid use in patients undergoing minimally invasive surgery (MIS) versus open surgery for nephrectomy. METHODS For opioid-naïve patients in Ontario who underwent nephrectomy for kidney cancer (1994-2017, n=7900), post-discharge opioid use was determined by prescriptions in the Ontario Drug Benefit database (age ≥65 years) and the Narcotics Monitoring System (all patients from 2012). Early opioid use was defined as ≥ 1 prescription 1-90 days after surgery. Two separate definitions of prolonged opioid use were examined: (1) prescription(s) for ≥ 60 days during post-operative days 90-365; (2) ≥ 1 prescriptions between both of: 1-90 days AND 91-180 days after surgery. Predictors of opioid use were assessed using multivariable generalized estimating equation logistic regression, accounting for surgeon clustering. RESULTS Overall, 67.4% of patients received early opioid prescriptions; however, prolonged use was low, ranging from 1.6 to 4.4% of patients depending on the definition. In multivariable analysis, open nephrectomy was associated with higher odds of early opioid use compared to MIS nephrectomy (Odds Ratio [OR] 1.36, 95% Confidence Interval [CI] 1.19-1.55). Surgery type was not significantly associated with prolonged opioid use for either definition (OR 1.22, CI 0.79 1.89 and OR 1.06, CI 0.83, 1.35). CONCLUSIONS In this population-level study of patients undergoing nephrectomy for kidney cancer, patients who received open surgery were at increased odds of receiving early post-operative opioids compared to MIS. Prolonged opioid use was low overall and was not significantly with associated with type of surgery.
Collapse
Affiliation(s)
- D C Cheung
- Division of Urology, Department of Surgery, University of Toronto, Toronto, Canada
| | - L J Martin
- Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre-University Health Network, Toronto, Canada
| | - N K Jivraj
- Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Canada
| | - H Clarke
- Department of Anesthesia and Pain Management, Toronto General Hospital, University Health Network, Toronto, Canada; Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, Canada
| | - T Gomes
- Institute of Health Policy Management and Evaluation, University of Toronto; Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Canada; ICES, Toronto, Canada
| | - D N Wijeysundera
- Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, Canada; ICES, Toronto, Canada; Department of Anesthesia, St. Michael's Hospital, Toronto, Canada
| | | | - M Nayan
- Division of Urology, Department of Surgery, University of Toronto, Toronto, Canada
| | - O Saarela
- Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
| | - Smh Alibhai
- Department of Medicine, University Health Network, University of Toronto, Canada
| | - M Komisarenko
- Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre-University Health Network, Toronto, Canada
| | - N E Fleshner
- Division of Urology, Department of Surgery, University of Toronto, Toronto, Canada; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre-University Health Network, Toronto, Canada
| | - G S Kulkarni
- Division of Urology, Department of Surgery, University of Toronto, Toronto, Canada; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre-University Health Network, Toronto, Canada
| | - A Finelli
- Division of Urology, Department of Surgery, University of Toronto, Toronto, Canada; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre-University Health Network, Toronto, Canada.
| |
Collapse
|
11
|
Murji A, Richard L, McArthur E, Austin P, Lipscombe L, Gomes T. Peri-Operative Opioid Prescribing Practices of Resident Trainees Compared with Staff Surgeons. J Minim Invasive Gynecol 2021. [DOI: 10.1016/j.jmig.2021.09.455] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
12
|
Olentino D, Lubich CCF, Rocha MDP, Santos JHN, Gomes T, Beltrão H, Silva JF, Yamamoto KC. Length-weight relationships of fish from sandy beaches. BRAZ J BIOL 2021; 83:e250003. [PMID: 34669803 DOI: 10.1590/1519-6984.250003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2021] [Accepted: 06/09/2021] [Indexed: 11/22/2022] Open
Abstract
This study estimated the length-weight relationships of 16 fish species occurring close to the shores of sandy beaches along the lower Negro River basin, Brazilian Amazon. The specimens were captured for one day each month, in October to November 2016, early in the morning and early evening, using trawl net (20 m taken for standard length (SL - 0.1 cm precision) and total weight (TW - 0.01 g precision). The parameters a and b of the equation WT = a.LTb were estimated. The a values ranged from 0.0018 to 0.0226 and b values ranged from 2.5271 to 3.3244. This study also provides new data on of maximum lengths for six species, Amazonsprattus scintilla, Brycon pesu, Moenkhausia megalops, Pachyurus paucirastrus, Reganella depressa and Trachydoras microstomus, and new reports of the LWRs parameters of 15 fish species.
Collapse
Affiliation(s)
- D Olentino
- Universidade Federal do Amazonas - UFAM, Programa de Educação Tutorial de Engenharia de Pesca - PET Pesca, Manaus, AM, Brasil
| | - C C F Lubich
- Universidade Federal do Amazonas - UFAM, Programa de Pós-graduação em Ciência Animal e Recursos Pesqueiros, Laboratório de Ecologia Pesqueira - LABEP, Manaus, AM, Brasil
| | - M D P Rocha
- Universidade Federal do Amazonas - UFAM, Programa de Educação Tutorial de Engenharia de Pesca - PET Pesca, Manaus, AM, Brasil
| | - J H N Santos
- Universidade Federal do Amazonas - UFAM, Programa de Educação Tutorial de Engenharia de Pesca - PET Pesca, Manaus, AM, Brasil
| | - T Gomes
- Universidade Federal do Amazonas - UFAM, Programa de Educação Tutorial de Engenharia de Pesca - PET Pesca, Manaus, AM, Brasil
| | - H Beltrão
- Universidade Federal do Amazonas - UFAM, Programa de Pós-graduação em Ciências Pesqueiras nos Trópicos, Manaus, AM, Brasil
| | - J F Silva
- Universidade Federal do Amazonas - UFAM, Laboratório de Ictiologia - LABIC, Manaus, AM, Brasil
| | - K C Yamamoto
- Universidade Federal do Amazonas - UFAM, Departamento de Ciências Pesqueiras, Laboratório de Ictiologia - LABIC, Manaus, AM, Brasil
| |
Collapse
|
13
|
Abdollah H, Brogly SB, Payne D, Lajkosz K, Coverdale NS, Gomes T, Hamilton A. P6476Surgery does not appear to improve survival in patients with endocarditis and substance use disorder. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.1067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Cohort studies of surgery compared with medical treatment (MT) on endocarditis mortality are conflicting. We conducted a population-based study to estimate associations between treatment and mortality.
Methods
1,381 patients with substance use disorder (SUD) and 5,053 without (NSUD) hospitalized for endocarditis were included. Treatment was modeled as a time-dependent variable: patients who underwent surgery after admission were classified as MT until surgery occurred and surgically treated thereafter. Patients without surgery were classified as MT. Adjusted hazard ratios (aHR) between treatment and death (in-hospital, 30 days, one, two, five years) by SUD status were estimated.
Results
Among SUD patients, there was a trend towards reduction in in-hospital death with surgery vs. MT (aHR 0.61 [95% CI: 0.35–1.04]), but no difference at 30 days (aHR 0.79 [95% CI: 0.42–1.48]). Mortality was higher in SUD patients who underwent surgery compared with MT at one (aHR 1.30 [95% CI: 0.95–1.76]), two (aHR 1.27 [95% CI: 0.97–1.65]), and five years (aHR 1.37 [95% CI: 1.09–1.72]). In NSUD patients, in-hospital mortality (aHR 0.93 [95% CI 0.76–1.16]) did not differ, but 30 day mortality (aHR 1.36 [95% CI 1.04–1.77]) was higher with surgery versus MT, and lower at one (aHR 0.87 [95% CI: 0.73–1.03]), two (aHR 0.75 [95% CI: 0.64–0.88]), and five years (aHR 0.70 [95% CI: 0.61–0.81]).
Kaplan-Meier Survival Curves of Patients
Interpretation
Surgery compared with MT conferred no long-term survival benefit in SUD patients. In NSUD patients, surgery was associated with an initial increased risk of early death followed by a lower risk after one year.
Acknowledgement/Funding
Grant from Department of Surgery, Queen's University
Collapse
Affiliation(s)
| | | | - D Payne
- Queen's University, Kingston, Canada
| | - K Lajkosz
- Queen's University, Kingston, Canada
| | | | - T Gomes
- St. Michael's Hospital, Toronto, Canada
| | | |
Collapse
|
14
|
Brooks SJ, Escudero-Oñate C, Gomes T, Ferrando-Climent L. An integrative biological effects assessment of a mine discharge into a Norwegian fjord using field transplanted mussels. Sci Total Environ 2018; 644:1056-1069. [PMID: 30743819 DOI: 10.1016/j.scitotenv.2018.07.058] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/05/2018] [Revised: 06/13/2018] [Accepted: 07/04/2018] [Indexed: 06/09/2023]
Abstract
The blue mussel (Mytilus sp.) has been used to assess the potential biological effects of the discharge effluent from the Omya Hustadmarmor mine, which releases its tailings into the Frænfjord near Molde, Norway. Chemical body burden and a suite of biological effects markers were measured in mussels positioned for 8 weeks at known distances from the discharge outlet. The biomarkers used included: condition index (CI); stress on stress (SoS); micronuclei formation (MN); acetylcholine esterase (AChE) inhibition, lipid peroxidation (LPO) and Neutral lipid (NL) accumulation. Methyl triethanol ammonium (MTA), a chemical marker for the esterquat based flotation chemical (FLOT2015), known to be used at the mine, was detected in mussels positioned 1500 m and 2000 m downstream from the discharge outlet. Overall the biological responses indicated an increased level of stress in mussels located closest to the discharge outlet. The same biomarkers (MN, SoS, NL) were responsible for the integrated biological response (IBR/n) of the two closest stations and indicates a response to a common point source. The integrated biological response index (IBR/n) reflected the expected level of exposure to the mine effluent, with the highest IBR/n calculated in mussels positioned closest to the discharge. Principal component analysis (PCA) also showed a clear separation between the mussel groups, with the most stressed mussels located closest to the mine tailing outlet. Although not one chemical factor could explain the increased stress on the mussels, highest metal (As, Co, Ni, Cd, Zn, Ag, Cu, Fe) and MTA concentrations were detected in the mussel group located closest to the mine discharge.
Collapse
Affiliation(s)
- S J Brooks
- Norwegian Institute for Water Research (NIVA), Gaustadalléen 21, NO-0349 Oslo, Norway.
| | - C Escudero-Oñate
- Norwegian Institute for Water Research (NIVA), Gaustadalléen 21, NO-0349 Oslo, Norway
| | - T Gomes
- Norwegian Institute for Water Research (NIVA), Gaustadalléen 21, NO-0349 Oslo, Norway
| | - L Ferrando-Climent
- Tracer Technology Department, Oil and Gas Section, Institute for Energy Technology, P.O. Box 40, NO-2027 Kjeller, Norway
| |
Collapse
|
15
|
Gomes T, Huynh N, Emami E. 0717 Comparaison Of Self-reported Objectives Sleep Measures In Elderly Population With Sleep Apnea. Sleep 2018. [DOI: 10.1093/sleep/zsy061.716] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- T Gomes
- University of Montreal, Montréal, QC, CANADA
| | - N Huynh
- University of Montreal, Montréal, QC, CANADA
| | - E Emami
- University of Montreal, Montréal, QC, CANADA
| |
Collapse
|
16
|
Brandão M, Rocha M, Silva J, Nascimento L, Gomes T, Conde B, Fernandes A. 222P Women: The other face of malignant pleural mesothelioma. J Thorac Oncol 2018. [DOI: 10.1016/s1556-0864(18)30494-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
17
|
Gomes T, Jimenez-Moreno A, Roos A. RNA toxicity versus GSK3B dysfunction in myotonic dystrophy type 1: an exploratory review of the literature. Neuromuscul Disord 2018. [DOI: 10.1016/s0960-8966(18)30309-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
18
|
Horrigan J, McMorn A, Snape M, Nikolenko N, Gomes T, Lochmuller H. AMO-02 (tideglusib) for the treatment of congenital and childhood onset myotonic dystrophy type 1. Neuromuscul Disord 2018. [DOI: 10.1016/s0960-8966(18)30330-4] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
19
|
Costa RA, Gomes T, Eira C, Vaqueiro J, Vingada JV. Great tit response to decreasing industrial heavy metal emissions. Ecotoxicology 2017; 26:802-808. [PMID: 28508143 DOI: 10.1007/s10646-017-1811-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 04/24/2017] [Indexed: 06/07/2023]
Abstract
This study evaluated the effects of environmental pollution on decreasing great tit (Parus major) breeding parameters in an industrial area in the west coast of Portugal. Several great tit breeding parameters were monitored in the industrial area, as well as in a rural area not affected by industrial emissions. Low levels of air pollution in both industrial and rural areas were confirmed by assessing trace element concentrations in pine needles. Concentrations of Cd and Hg in pine needles from the industrial area (Cd = 0.05 ppm; Hg = 0.005 ppm) were significantly lower than those found in needles collected from the reference area (Cd = 0.07 ppm; Hg = 0.007 ppm). Additionally, the breeding success of great tits increased in the industrial area in comparison to the reference area (0.93 ± 0.08 and 0.62 ± 0.22, respectively). The changes on great tit breeding parameters were probably related with changes in the breeding density of other competitive species, together with a decreasing frass-fall biomass. Further long-term ecological studies in industrial areas are necessary to understand the changing breeding performance and strategies used by great tits in response to pollution shifts in the environment.
Collapse
Affiliation(s)
- R A Costa
- Departamento de Biologia & CESAM, Universidade de Aveiro, Campus de Santiago, Aveiro, 3810-193, Portugal.
| | - T Gomes
- Departamento de Biologia/CBMA, Universidade do Minho, Campus de Gualtar, Braga, 4710-057, Portugal
| | - C Eira
- Departamento de Biologia & CESAM, Universidade de Aveiro, Campus de Santiago, Aveiro, 3810-193, Portugal
- Sociedade Portuguesa de Vida Selvagem, Estação de Campo de Quiaios, Apartado 16 EC Quiaios, Figueira da Foz, 3081-101, Portugal
| | - J Vaqueiro
- Departamento de Biologia/CBMA, Universidade do Minho, Campus de Gualtar, Braga, 4710-057, Portugal
- Sociedade Portuguesa de Vida Selvagem, Estação de Campo de Quiaios, Apartado 16 EC Quiaios, Figueira da Foz, 3081-101, Portugal
| | - J V Vingada
- Departamento de Biologia/CBMA, Universidade do Minho, Campus de Gualtar, Braga, 4710-057, Portugal
- Sociedade Portuguesa de Vida Selvagem, Estação de Campo de Quiaios, Apartado 16 EC Quiaios, Figueira da Foz, 3081-101, Portugal
- CESAM, Universidade de Aveiro, Campus de Santiago, Aveiro, 3810-193, Portugal
| |
Collapse
|
20
|
Lee J, Muratov S, Tarride J, Paterson M, Gomes T, Khuu W, Holbrook A. SENIOR HIGH COST HEALTHCARE USERS: HOW DO THEY DIFFER? Innov Aging 2017. [DOI: 10.1093/geroni/igx004.222] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- J. Lee
- Division of Geriatric Medicine, McMaster University, Hamilton, Ontario, Canada,
- Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Ontario, Canada,
- Geriatric Education and Research in Aging Sciences (GERAS) Centre, Hamilton, Ontario, Canada,
| | - S. Muratov
- Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Ontario, Canada,
- Program for Assessment of Technologies and Health (PATH) Research Institute, St. Joseph’s Healthcare Hamilton, Hamilton, Ontario, Canada
| | - J. Tarride
- Program for Assessment of Technologies and Health (PATH) Research Institute, St. Joseph’s Healthcare Hamilton, Hamilton, Ontario, Canada
| | - M. Paterson
- Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada,
| | - T. Gomes
- Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto, Ontario, Canada,
- Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada,
| | - W. Khuu
- Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada,
| | - A. Holbrook
- Division of Clinical Pharmacology, McMaster University, Hamilton, Ontario, Canada,
- Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Ontario, Canada,
- Centre for Evaluation of Medicines, Hamilton, Ontario, Canada,
| |
Collapse
|
21
|
Valverde J, Vinagreiro M, Gouveia P, Koch P, Soares V, Gomes T. Sarcoma the great "masquerader" hematoma/deep vein thrombosis manifestation. Int J Surg Case Rep 2016; 28:348-351. [PMID: 27792978 PMCID: PMC5090197 DOI: 10.1016/j.ijscr.2016.10.041] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2016] [Accepted: 10/15/2016] [Indexed: 11/29/2022] Open
Abstract
INTRODUCTION The clinical presentation of patients with soft-tissue sarcoma is highly variable. Most patients present with a painless mass, typically one that is increasing in size, and few have systemic symptoms such as fever, weight loss, or malaise. Soft tissue sarcomas can initially present as, or even be misdiagnosed as, deep venous thrombosis (DVT), leading to a late diagnosis. CASE REPORT A 51-year-old woman presented to the hospital with complaints of pain and swelling in her left thigh, interpreted as an infected hematoma with an associated deep vein thrombosis and treated accordingly. The patient presented to our emergency department two more times. In the last visit and due to an unresolving clinical scenario a MRI and surgical byopsies were made that confirmed a sarcoma diagnosis. DISCUSSION When a patient presents with an expanding, nontraumatic mass simulating a haematoma, several other differential diagnoses should be considered including aneurysm, bleeding tendency, chronic expanding haematoma and soft-tissue sarcoma. The growth of the tumor undetected while being treated for the DVT and then posteriorly for the hematoma, was without a doubt dismal to the patient, so earlier diagnosis would have been preferable. CONCLUSION When a patient presents with an unusual history of hematoma in the extremities, it is necessary to consider the possibility of a malignant soft tissue tumor.
Collapse
Affiliation(s)
- J Valverde
- Rua Dr. Eduardo Torres, 4464-513 Senhora da Hora, Portugal.
| | - M Vinagreiro
- Rua Dr. Eduardo Torres, 4464-513 Senhora da Hora, Portugal
| | - P Gouveia
- Rua Dr. Eduardo Torres, 4464-513 Senhora da Hora, Portugal
| | - P Koch
- Rua Dr. Eduardo Torres, 4464-513 Senhora da Hora, Portugal
| | - V Soares
- Rua Dr. Eduardo Torres, 4464-513 Senhora da Hora, Portugal
| | - T Gomes
- Rua Dr. Eduardo Torres, 4464-513 Senhora da Hora, Portugal
| |
Collapse
|
22
|
Crisóstomo S, Cardigos J, Costa L, Basílio A, Anjos R, Cardoso M, Gomes T. Ab Interno Collagen Stent implantation as a treatment option for open angle glaucoma. Acta Ophthalmol 2016. [DOI: 10.1111/j.1755-3768.2016.0519] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
23
|
Costa L, Cardigos J, Crisostomo S, Anjos R, Sa Cardoso M, Gomes T. Macroscopic analysis of filtering bleb functionality after XEN Gel Stent implantation with Anterior Segment Optical Coherence Tomography. Acta Ophthalmol 2016. [DOI: 10.1111/j.1755-3768.2016.0638] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
24
|
Cardigos J, Crisostomo S, Costa L, Anjos R, Vieira L, Cardoso M, Reina M, Gomes T. Filtering blebs after XEN implantation and trabeculectomy: a clinical and in vivo
confocal microscopy study. Acta Ophthalmol 2016. [DOI: 10.1111/j.1755-3768.2016.0473] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
25
|
Bebianno MJ, Sroda S, Gomes T, Chan P, Bonnafe E, Budzinski H, Geret F. Proteomic changes in Corbicula fluminea exposed to wastewater from a psychiatric hospital. Environ Sci Pollut Res Int 2016; 23:5046-5055. [PMID: 26423280 DOI: 10.1007/s11356-015-5395-5] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/30/2014] [Accepted: 09/08/2015] [Indexed: 06/05/2023]
Abstract
The increase use of pharmaceutical compounds in veterinary practice and human population results in the ubiquitous presence of these compounds in aquatic ecosystems. Because pharmaceuticals are highly bioactive, there is concern about their toxicological effects in aquatic organisms. Therefore, the aim of this study was to assess the effects of an effluent from a psychiatric hospital (containing a complex mixture of 25 pharmaceutical compounds from eleven therapeutic classes) on the freshwater clam Corbicula fluminea using a proteomic approach. The exposure of C. fluminea to this complex effluent containing anxiolytics, analgesics, lipid regulators, beta blockers, antidepressants, antiepileptics, antihistamines, antihypertensives, antiplatelets and antiarrhythmics induced protein changes after 1 day of exposure in clam gills and digestive gland more evident in the digestive gland. These changes included increase in the abundance of proteins associated with structural (actin and tubulin), cellular functions (calreticulin, proliferating cell nuclear antigen (PCNA), T complex protein 1 (TCP1)) and metabolism (aldehyde dehydrogenase (ALDH), alcohol dehydrogenase, 6 phosphogluconate dehydrogenase). Results from this study indicate that calreticulin, PCNA, ALDH and alcohol dehydrogenase in the digestive gland and T complex protein 1 (TCP1)) and 6 phosphogluconate dehydrogenase in the gills represent useful biomarkers for the ecotoxicological characterization of psychiatric hospital effluents in this species.
Collapse
Affiliation(s)
- M J Bebianno
- CIMA, University of Algarve, Campus Gambelas, 8005-139, Faro, Portugal.
| | - S Sroda
- Laboratory of Alpine Ecology - LECA UMR-CNRS 5553, Equipe P3E 2233, rue de la piscine Campus Universitaire de Grenoble, 38400, Saint Martin d'Hères, France
| | - T Gomes
- CIMA, University of Algarve, Campus Gambelas, 8005-139, Faro, Portugal
| | - P Chan
- PISSARO Proteomic plateform, IRIB, University of Rouen, 76821, Mont-Saint-Aignan Cedex, France
| | - E Bonnafe
- Centre Universitaire J. F. Champollion, Place de Verdun, 81012, Albi Cedex 12, France
| | - H Budzinski
- Laboratory of Physico and Toxico-Chemistry of the Environment, UMR EPOC CNRS 5805, University Bordeaux 1, 351 cours de la Libération, 33405, Talence, France
| | - F Geret
- Laboratory GEODE, UMR CNRS 5602, University of Toulouse, Centre Universitaire J.F. Champollion, Place de Verdun, 81012, Albi Cedex 12, France
| |
Collapse
|
26
|
Bebianno MJ, Gonzalez-Rey M, Gomes T, Mattos JJ, Flores-Nunes F, Bainy ACD. Is gene transcription in mussel gills altered after exposure to Ag nanoparticles? Environ Sci Pollut Res Int 2015; 22:17425-17433. [PMID: 26278907 DOI: 10.1007/s11356-015-5186-z] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/21/2015] [Accepted: 08/10/2015] [Indexed: 06/04/2023]
Abstract
Nanotechnology is a rapid field of development with the enhancement of the production of different types of nanoparticles (NPs) applied in several industrial and commercial applications which increase the risk of their presence in the aquatic environment. Ag NPs have a wide application in everyday life products. However, there is concern about the exposure effects on aquatic organisms to these NPs. Therefore, this study aims to assess gene transcription alterations in mussels Mytilus galloprovincialis gills exposed for 2 weeks to Ag NPs (42 ± 10 nm, 10 μg.L(-1)). The genes were selected based on previous biomarkers and proteomic results and included superoxide dismutase (SOD), catalase (CAT), glutathione transferase (GST), caspase 3/7-1 (CAS), cathepsin L (CATH), heat-shock protein 70 (HSP 70), cytochrome P450 4YA (CYP 4YA), the elongation factor (EF1), actin and α- tubulin. No significant changes in gene transcription profiles were observed after exposure of M. galloprovincialis to Ag NPs for 15 days. The lack of significant gene transcription responses is in light with previous results obtained for mussels exposed to these NPs and may be related to the fact that enzyme kinetics and relative abundance of proteins (increase of antioxidant enzymes and metalllothioneins (MTs) with the time of exposure) do not always directly reflect their relative mRNA levels. Nevertheless, their overall expression maintenance may signify that, at end of the exposure period (15 days), the transcription of the respective genes is no longer required, pointing out to a possible adaptation effect to nanoparticles or due to the levels of Ag NPs accumulated in this tissue at this exposure time. This study highlights that gene transcription application and role as an additional and/or alternative end point approach is important to understand the mode of action of these emergent contaminants in aquatic organisms. However, in future studies, the time window needs to be adjusted, as genes are likely to respond earlier to the nanoparticle exposure.
Collapse
Affiliation(s)
- M J Bebianno
- CIMA, Marine and Environmental Research Center, University of Algarve, Campus de Gambelas, 8000135, Faro, Portugal.
| | - M Gonzalez-Rey
- CIMA, Marine and Environmental Research Center, University of Algarve, Campus de Gambelas, 8000135, Faro, Portugal
| | - T Gomes
- CIMA, Marine and Environmental Research Center, University of Algarve, Campus de Gambelas, 8000135, Faro, Portugal
| | - J J Mattos
- LABCAI, Department of Biochemistry, Federal University of Santa Catarina, 88034-257, Florianopolis, SC, Brazil
| | - F Flores-Nunes
- LABCAI, Department of Biochemistry, Federal University of Santa Catarina, 88034-257, Florianopolis, SC, Brazil
| | - A C D Bainy
- LABCAI, Department of Biochemistry, Federal University of Santa Catarina, 88034-257, Florianopolis, SC, Brazil
| |
Collapse
|
27
|
Schujmann D, Gomes T, da Silveira LTY, Fu C. Quantifying physical activity levels of patients in intensive care: an objective measurement. Physiotherapy 2015. [DOI: 10.1016/j.physio.2015.03.1288] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
28
|
Schujmann D, Gomes T, da Silveira LTY, Fu C. Correlation between different levels of activity during the stay in ICU and functional decline in discharge. Physiotherapy 2015. [DOI: 10.1016/j.physio.2015.03.1287] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
29
|
Nascimento LM, Gomes T, Fernandes A, Afonso A. Solitary fibrous tumors of the pleura: not always a benign entity. Rev Port Pneumol (2006) 2015; 21:103-5. [PMID: 25926376 DOI: 10.1016/j.rppnen.2014.11.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2014] [Accepted: 11/28/2014] [Indexed: 10/24/2022] Open
Affiliation(s)
- L M Nascimento
- Department of Pulmonology, Centro Hospitalar de Trás-os-Montes e Alto, Vila Real, Portugal.
| | - T Gomes
- Department of Pulmonology, Centro Hospitalar de Trás-os-Montes e Alto, Vila Real, Portugal
| | - A Fernandes
- Department of Pulmonology, Centro Hospitalar de Trás-os-Montes e Alto, Vila Real, Portugal
| | - A Afonso
- Department of Pulmonology, Centro Hospitalar de Trás-os-Montes e Alto, Vila Real, Portugal
| |
Collapse
|
30
|
Ladeira I, Gomes T, Castro A, Ribeiro C, Guimarães M, Taveira N. The overall impact of COPD (CAT) and BODE index on COPD male patients: correlation? Rev Port Pneumol (2006) 2015; 21:11-15. [PMID: 25854130 DOI: 10.1016/j.rppnen.2014.02.004] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2013] [Accepted: 02/22/2014] [Indexed: 06/04/2023] Open
Abstract
BACKGROUND Chronic Obstructive Pulmonary Disease (COPD) will be the 5th leading cause of disability (DALYs) and the 4th leading cause of death by 2030. Measuring the real impact of COPD using CAT ("COPD Assessment Test") can complement BODE index, an indicator of mortality. AIMS To assess correlation between CAT and BODE index in COPD patients. MATERIALS AND METHODS A retrospective study was conducted in a population of patients with COPD in a Respiratory Rehabilitation program. We analyzed demographic variables, variables in respiratory function--6 min walking test (6 MWT), post-BD forced expiratory volume in 1st second (FEV1%); dyspnea by mMRC scale; BODE Index and CAT. RESULTS The study included 50 patients--GOLD stage I (7), II (25), III (14) and IV (4), 48 men; mean age 62.6 years (± 9.5), average BMI 25.8 kg/m(2) (± 4.8) and FEV1 57.1% (± 19.6); 6 MWT of 443.3m (± 61.6); 46% patients in classes 2 and 3 of mMRC scale; 84% were class 2 in BODE Index. About 80% reported slight to medium impact in CAT. CAT score and impact were correlated with BODE index score: R=0.475, p<0.01, and R=0.377, p=0.004, and BODE index class: R=0.357, p=0.011, and R=0.326, p=0.021. CONCLUSION As pre-existent data in the literature (exacerbations and benefit of rehabilitation in COPD), the positive correlations found with BODE index reinforce the discriminative validity of CAT as a complement in the evaluation of what the true impact of COPD is on a patient's daily life.
Collapse
Affiliation(s)
- I Ladeira
- Resident in the Pulmonology Department of Centro Hospitalar Vila Nova de Gaia/Espinho, EPE, Portugal.
| | - T Gomes
- Resident in the Pulmonology Department of Centro Hospitalar Trás-os-Montes e Alto Douro, EPE, Portugal
| | - A Castro
- Pulmonology Assistant in Centro Hospitalar de Vila Nova de Gaia/Espinho, EPE, Portugal
| | - C Ribeiro
- Resident in the Pulmonology Department of Centro Hospitalar Vila Nova de Gaia/Espinho, EPE, Portugal
| | - M Guimarães
- Pulmonology Assistant in Centro Hospitalar de Vila Nova de Gaia/Espinho, EPE, Portugal
| | - N Taveira
- Pulmonology Graduate Assistant in Centro Hospitalar de Vila Nova de Gaia/Espinho, EPE, Portugal
| |
Collapse
|
31
|
Ladeira I, Gomes T, Castro A, Ribeiro C, Guimarães M, Taveira N. WITHDRAWN: The overall impact of COPD (CAT) and BODE index on COPD male patients: correlation? Rev Port Pneumol 2014:S0873-2159(14)00043-9. [PMID: 24814568 DOI: 10.1016/j.rppneu.2014.02.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2013] [Revised: 02/19/2014] [Accepted: 02/22/2014] [Indexed: 10/25/2022] Open
Abstract
This article has been withdrawn for editorial reasons because the journal will be published only in English. In order to avoid duplicated records, this article can be found at http://dx.doi.org/10.1016/j.rppnen.2014.02.004. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.
Collapse
Affiliation(s)
- I Ladeira
- Resident in the Pulmonology Department of Centro Hospitalar Vila Nova de Gaia/Espinho, EPE, Portugal.
| | - T Gomes
- Resident in the Pulmonology Department of Centro Hospitalar Trás-os-Montes e Alto Douro, EPE, Portugal
| | - A Castro
- Pulmonology Assistant in Centro Hospitalar de Vila Nova de Gaia/Espinho, EPE, Portugal
| | - C Ribeiro
- Resident in the Pulmonology Department of Centro Hospitalar Vila Nova de Gaia/Espinho, EPE, Portugal
| | - M Guimarães
- Pulmonology Assistant in Centro Hospitalar de Vila Nova de Gaia/Espinho, EPE, Portugal
| | - N Taveira
- Pulmonology Graduate Assistant in Centro Hospitalar de Vila Nova de Gaia/Espinho, EPE, Portugal
| |
Collapse
|
32
|
Musselman R, Li W, Gomes T, Mamdani M, Haggar F, Moloo H, Boushey R, Al-Omran M, Al-Obeed O, VanWalraven C, Auer R. Association Between Beta Blocker Usage and Cancer Survival in a Large, Matched Population Study Among Hypertensive Patients. J Surg Res 2014. [DOI: 10.1016/j.jss.2013.11.661] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
33
|
Maria VL, Gomes T, Barreira L, Bebianno MJ. Impact of benzo(a)pyrene, Cu and their mixture on the proteomic response of Mytilus galloprovincialis. Aquat Toxicol 2013; 144-145:284-295. [PMID: 24211336 DOI: 10.1016/j.aquatox.2013.10.009] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/12/2013] [Revised: 10/07/2013] [Accepted: 10/08/2013] [Indexed: 06/02/2023]
Abstract
In natural waters, chemical interactions between mixtures of contaminants can result in potential synergistic and/or antagonic effects in aquatic animals. Benzo(a)pyrene (BaP) and copper (Cu) are two widespread environmental contaminants with known toxicity towards mussels Mytilus spp. The effects of the individual and the interaction of BaP and Cu exposures were assessed in mussels Mytilus galloprovincialis using proteomic analysis. Mussels were exposed to BaP [10 μg L(-1) (0.396 μM)], and Cu [10 μg L(-1) (0.16 μM)], as well as to their binary mixture (mixture) for a period of 7 days. Proteomic analysis showed different protein expression profiles associated to each selected contaminant condition. A non-additive combined effect was observed in mixture in terms of new and suppressed proteins. Proteins more drastically altered (new, suppressed and 2-fold differentially expressed) were excised and analyzed by mass spectrometry, and eighteen putatively identified. Protein identification demonstrated the different accumulation, metabolism and chemical interactions of BaP, Cu and their mixture, resulting in different modes of action. Proteins associated with adhesion and motility (catchin, twitchin and twitchin-like protein), cytoskeleton and cell structure (α-tubulin and actin), stress response (heat shock cognate 71, heat shock protein 70, putative C1q domain containing protein), transcription regulation (zinc-finger BED domain-containing and nuclear receptor subfamily 1G) and energy metabolism (ATP synthase F0 subunit 6 protein and mannose-6-phosphate isomerase) were assigned to all three conditions. Cu exposure alone altered proteins associated with oxidative stress (glutathione-S-transferase) and digestion, growth and remodelling processes (chitin synthase), while the mixture affected only one protein (major vault protein) possibly related to multi drug resistance. Overall, new candidate biomarkers, namely zinc-finger BED domain-containing protein, chitin synthase and major vault protein, were also identified for BaP, Cu and mixture, respectively.
Collapse
Affiliation(s)
- V L Maria
- CIMA, Faculty of Sciences and Technology, University of Algarve, Campus de Gambelas, 8005-139 Faro, Portugal.
| | | | | | | |
Collapse
|
34
|
Foster PD, Mamdani MM, Juurlink DN, Shah BR, Paterson JM, Gomes T. Trends in selection and timing of first-line pharmacotherapy in older patients with type 2 diabetes diagnosed between 1994 and 2006. Diabet Med 2013; 30:1209-13. [PMID: 23586333 DOI: 10.1111/dme.12214] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 04/10/2013] [Indexed: 11/30/2022]
Abstract
AIMS To characterize temporal trends in the selection and timing of first-line pharmacotherapy among older patients with Type 2 diabetes. DESIGN AND METHODS We studied five population-based cohorts every 3 years, from 1994 to 2006. In each of those years, we identified all subjects aged 66 years or older newly diagnosed with diabetes and determined the initial glucose-lowering drug and the time between diagnosis and drug initiation. We calculated the proportion of patients prescribed each agent and estimated time from diagnosis to initiation using Kaplan-Meier survival analysis. RESULTS We identified a total of 64 368 eligible people who initiated drug therapy during the study period. From 1994 to 2006, first-line metformin use increased from 20.1 to 79.0%. Glyburide (glibenclamide) decreased from 71.1% of all first-line therapies in 1994 to 9.8% in 2006, while first-line use of insulin or combination therapy have changed little at approximately 5% each. No other medication exceeded 2% of first-line therapies. The median time from diagnosis to initiation of pharmacotherapy increased dramatically during the study period, from 1.8 years in 1994 to 4.6 years in 2006. CONCLUSIONS Metformin has become the most commonly used initial medication for the treatment of diabetes. Although guidelines have evolved to recommend more aggressive initiation and intensification of pharmacotherapy, our results suggest that the time from diagnosis to initiation has increased substantially.
Collapse
Affiliation(s)
- P D Foster
- Schulich School of Medicine and Dentistry, University of Western Ontario, London; Applied Health Research Centre, St. Michael's Hospital, Toronto, ON, Canada
| | | | | | | | | | | |
Collapse
|
35
|
Butt DA, Mamdani M, Austin PC, Tu K, Gomes T, Glazier RH. The risk of falls on initiation of antihypertensive drugs in the elderly. Osteoporos Int 2013; 24:2649-57. [PMID: 23612794 DOI: 10.1007/s00198-013-2369-7] [Citation(s) in RCA: 79] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/28/2013] [Accepted: 04/05/2013] [Indexed: 02/06/2023]
Abstract
SUMMARY Antihypertensive drugs are associated with an immediate increased falls risk in elderly patients which was significant during the first 14 days after receiving a thiazide diuretic, angiotensin-converting enzyme inhibitor, angiotensin II receptor blocker, calcium channel blocker, or beta-adrenergic blocker. Fall prevention strategies during this period may prevent fall-related injuries. INTRODUCTION The purpose of this study is to evaluate if initiation of the common antihypertensive drugs is associated with the occurrence of falls. METHODS This population-based self-controlled case series study used healthcare administrative databases to identify new users of antihypertensive drugs in the elderly aged 66 and older living in Ontario, Canada who suffered a fall from April 1, 2000 to March 31, 2009. The risk period was the first 45 days following antihypertensive therapy initiation, further subdivided into 0-14 and 15-44 days with control periods before and after treatment in a 450-day observation period. We calculated the relative incidence (incidence rate ratio, IRR), defined as the rate of falls in the risk period compared to falls rate in the control periods. RESULTS Of the 543,572 new users of antihypertensive drugs among community-dwelling elderly, 8,893 experienced an injurious fall that required hospital care during the observation period. New users had a 69 % increased risk of having an injurious fall during the first 45 days following antihypertensive treatment (IRR = 1.69; 95 % CI, 1.57-1.81). This finding was consistent for thiazide diuretics, angiotensin-converting enzyme inhibitors, calcium channel blockers, and beta-adrenergic blockers but not angiotensin II receptor antagonists. There was also an increased falls risk during the first 14 days of antihypertensive drug initiation (IRR = 1.94; 95 % CI, 1.75-2.16), which was consistent for all antihypertensive drug classes. CONCLUSIONS This study suggests that initiation of antihypertensive drugs is a risk factor for falls in the elderly. Fall prevention strategies during this period may reduce injuries.
Collapse
Affiliation(s)
- D A Butt
- Department of Family and Community Medicine, The Scarborough Hospital, University of Toronto, Toronto, Ontario, Canada,
| | | | | | | | | | | |
Collapse
|
36
|
Gomes T, Juurlink DN, Shah BR, Hellings CR, Paterson JM, Mamdani MM. Progression through diabetes therapies among new elderly users of metformin: a population-based study. Diabet Med 2013; 30:e51-5. [PMID: 23075391 DOI: 10.1111/dme.12049] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/24/2012] [Revised: 08/09/2012] [Accepted: 10/15/2012] [Indexed: 11/27/2022]
Abstract
AIMS To examine temporal changes in progression to second-line therapies among older patients with diabetes newly treated with metformin. METHODS We conducted a population-based study among residents of Ontario, Canada aged 66 years and older with diabetes newly treated with metformin monotherapy in 1997, 2000, 2003 or 2006. Each annual cohort was followed until progression to a second oral hypoglycaemic agent, insulin or until 31 December 2010. Time to progression to a second oral hypoglycaemic agent or insulin was compared across the cohorts. RESULTS In the four annual cohorts, we identified a total of 46 104 people newly treated with metformin monotherapy. The median time to progression to any second diabetes therapy lengthened significantly over time, from 5.0 years in 1997 to 6.1 years in 2003 (P < 0.0001). Similarly, the time to progression to insulin lengthened over the study period (P = 0.03). Furthermore, the choice of second-line therapy changed over time. While 80.7% of new metformin users in 1997 progressed to glyburide therapy as second-line treatment, the corresponding figure by 2006 was only 45.1% as newer treatment options emerged. CONCLUSIONS Although recent guidelines recommend aggressive intensification of oral therapy for patients with Type 2 diabetes, older Ontarians with diabetes who started metformin in 2006 remained on monotherapy for longer than those who started in 1997. Furthermore, although there is no consensus regarding a preferred second-line therapy, the introduction of new alternatives has led to greater variation in the selection of second-line therapies in this population.
Collapse
Affiliation(s)
- T Gomes
- Institute for Clinical Evaluative Sciences; The Leslie Dan Faculty of Pharmacy, University of Toronto, Ontario, Canada.
| | | | | | | | | | | |
Collapse
|
37
|
Abstract
AIMS Sulphonylureas promote insulin release by inhibiting pancreatic potassium channels. Older sulphonylureas such as glyburide (glibenclamide), but not newer ones such as gliclazide, antagonize similar channels in myocardium, interfering with the protective effects of ischaemic preconditioning. Whether this imparts a higher risk of adverse cardiac events is unknown. METHODS We conducted a population-based cohort study of patients aged 66 years and older who were hospitalized for acute myocardial infarction or who underwent percutaneous coronary intervention between 1 April 2007 and 31 March 2010 while receiving either glyburide or gliclazide. We used a high-dimensional propensity score matching process to ensure similarity of glyburide- and gliclazide-treated patients. The primary outcome was a composite of death or hospitalization for myocardial infarction or heart failure. RESULTS During the 2-year study period, we matched 1690 patients treated with glyburide to 984 patients treated with gliclazide at the time of hospitalization for acute myocardial infarction or percutaneous coronary intervention. We found no difference in the risk of the composite outcome among patients receiving glyburide (adjusted hazard ratio 1.01; 95% CI 0.86-1.18). We found similar results in secondary analyses of each outcome individually, and in two supplementary analyses (haemorrhage and pneumonia) in which we anticipated no difference between the two patient groups. CONCLUSIONS Among older patients hospitalized for acute myocardial infarction or percutaneous coronary intervention, treatment with glyburide is not associated with an increased risk of future adverse cardiovascular events relative to gliclazide, suggesting that the effect of glyburide on ischaemic preconditioning is of little clinical relevance.
Collapse
Affiliation(s)
- D N Juurlink
- Department of Medicine, University of Toronto, Toronto, ON, Canada.
| | | | | | | |
Collapse
|
38
|
Musselman RP, Gomes T, Chan BP, Auer RC, Moloo H, Mamdani M, Al-Omran M, Al-Obeed O, Boushey RP. Changing trends in rectal cancer surgery in Ontario: 2002-2009. Colorectal Dis 2012; 14:1467-72. [PMID: 22487101 DOI: 10.1111/j.1463-1318.2012.03044.x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
AIM The safety and efficacy of laparoscopic surgery for colon cancer have been demonstrated in large, multicentre clinical trials. The study aimed to determine the use of laparoscopic surgery for rectal cancer in Ontario over a 7-year period. METHOD We conducted a retrospective study examining rates of elective rectal cancer surgery among 10.5 million adults in Ontario, Canada, from 1 April 2002 to 31 March 2009. We linked the Canadian Institute for Health Information Discharge Abstract Database, the Registered Persons Database and the database of the Ontario Cancer Registry to assess procedures used over the period. Data on demographics were collected. Trends were assessed using time series analysis. RESULTS Over the 7-year period, 8189 open and 1079 laparoscopic elective operations for rectal cancer were identified. The annual rate of laparoscopic rectal cancer procedures increased from 0.60 per 100,000 population in 2003 to 2.24 per 100,000 population in 2008 (P < 0.01). Laparoscopic patients were similar to open with respect to age (66.5 ± 11.8 vs 66.2 ± 12.1 years; standardized difference 0.02), gender (63.2%vs 59.4%; standardized difference 0.08), Charlson Comorbidity Index score (standardized difference < 0.1) and socioeconomic status (standardized difference < 0.1). CONCLUSION Laparoscopic rectal cancer surgery rates are increasing in Ontario. Ongoing research regarding the long-term safety and effectiveness of the laparoscopic approach for rectal cancer surgeries may lead to greater increases in its utilization.
Collapse
Affiliation(s)
- R P Musselman
- Department of Surgery, University of Ottawa, Ottawa, Ontario, Canada.
| | | | | | | | | | | | | | | | | |
Collapse
|
39
|
Pincus D, Gomes T, Hellings C, Zheng H, Paterson JM, Mamdani MM, Juurlink DN. A population-based assessment of the drug interaction between levothyroxine and warfarin. Clin Pharmacol Ther 2012; 92:766-70. [PMID: 23093318 DOI: 10.1038/clpt.2012.171] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Most drug interaction resources suggest that levothyroxine can dramatically potentiate the effect of warfarin. However, the mechanistic basis of the interaction is speculative, and little evidence supports a meaningful drug interaction. We conducted a population-based nested case-control study to examine the risk of hospitalization for hemorrhage following the initiation of levothyroxine in a cohort of 260,076 older patients receiving warfarin. In this group, we identified 10,532 case subjects hospitalized for hemorrhage and 40,595 controls. In the primary analysis, we found no association between hospitalization for hemorrhage during warfarin therapy and initiation of levothyroxine in the preceding 30 days (adjusted odds ratio 1.11, 95% confidence interval 0.67-1.86). Secondary analyses using more remote initiation of levothyroxine also found no association. These findings suggest that concerns about a clinically meaningful levothyroxine-warfarin drug interaction are not justified. Drug interaction resources that presently characterize this interaction as important should reevaluate this classification.
Collapse
Affiliation(s)
- D Pincus
- Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
| | | | | | | | | | | | | |
Collapse
|
40
|
Abstract
AIM The safety and efficacy of laparoscopic surgery for colon cancer is well established but its uptake in the province has not been previously explored. We report an investigation of the trends of open and laparoscopic surgery for colon cancer in Ontario, Canada. METHOD A retrospective cross-sectional time-series analysis examining population-based rates of elective surgery for colon cancer among 10.5 million adults in Ontario was conducted from 1 April 2002 to 31 March 2009. Databases were linked to assess quarterly elective procedure rates over time. RESULTS During the study period, 3950 laparoscopic and 13 048 open elective colon cancer operations were performed in Ontario. The overall quarterly rate of colon cancer surgery remained stable at an average of 5.8 per 100000 population (P=0.10). From the first and last quarter, the rate of laparoscopic operations increased nearly threefold from 0.8 to 2.2 per 100000 population with a notable increase after 2005 (P<0.01). In contrast, open surgery decreased by more than 30% from 5.3 to 3.5 per 100 000 population (P<0.01). If current trends continue, the projected proportion of laparoscopic colon operations is estimated to reach 41% by 2015. Patients receiving open surgery had a significantly higher preoperative comorbidity (Charlson comorbidity score≥3) than those having laparoscopy (47.8%vs 39.1%, standardized difference 0.26). CONCLUSION Trends in Ontario of laparoscopic colon cancer surgery show an increase between 2002 and 2009, but the incidence remains lower than for open surgery.
Collapse
Affiliation(s)
- B P Chan
- Division of General Surgery, Ottawa Hospital, University of Ottawa, Ontario, Canada.
| | | | | | | | | | | | | | | | | |
Collapse
|
41
|
Gomes T, Pereira C, Cardoso C, Pereira R, Almeida A, Pinheiro J, Cancio I, Cravo A, Bebianno M. Effects of Ag nanoparticles versus ionic Ag in Mytilus galloprovincialis. Comp Biochem Physiol A Mol Integr Physiol 2012. [DOI: 10.1016/j.cbpa.2012.05.038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
42
|
Fayez R, AlMuntashery A, Bodie G, Almamar A, Gill R, Raîche I, Mueller C, AlMuntashery A, Fayez R, AlMuntashery A, Moustarah F, Khokhotva M, Anvari M, Kwong J, Elkassem S, Bonrath E, Zevin B, Sockalingam S, Smith C, Smith C, Whitlock K, Gill R, Suri M, Palter V, Wakeam E, Khan R, Martelli V, Malik A, Young P, Daigle C, McCreery G, Seth R, Paskar D, Sudarshan M, Richardson D, Haggar F, Davis V, Rivard J, Agzarian J, Racz J, Winocour J, Zilbert N, Decker C, Neumann K, Gosney J, Wissanji H, Chadi S, Alhabboubi M, Partridge E, Alhabboubi M, Olszewski M, Chan R, Nadler A, Hameed U, Brotherhood H, Menezes A, MacDonald B, Rakovich G, Hilsden R, Merani S, Davis P, Davis P, Cools-Lartigue J, Ojah J, Julien F, Carter D, Pitt D, Banks B, Rudovics A, Ravichandran P, Anantha R, Aad I, Kholdebarin R, Aird L, Wong S, Payne J, Hallet J, Farries L, Raiche I, Botkin C, Morency D, Berger-Richardson D, Isa A, Dupuis I, Schweigert M, Koubi S, Ernjakovic M, Grant K, Cools-Lartigue J, Carrott P, Stafford T, Malthaner R, Sudarshan M, Hanna W, Lee L, Markar S, Razzak R, Bharadwaj S, Ashrafi A, Ouellette D, Fergusson D, Forster A, Boushey R, Porter G, Johnson P, Gomes T, Chan B, Auer R, Moloo H, Mamdani M, Markar S, Al-Omran M, Al-Obaid O, Boushey R, Lim DR, Min BS, Baik SH, Gordon P, Kim NK, Lo A, Pinsk I, Bottoni D, Brown C, Raval M, Cheng H, Wong C, Johnston N, Farrokhyar F, Stephen W, Kelly S, Lindsay L, Forbes S, Knickle C, Bouchard A, Parry N, Leslie K, Ott M, Coughlin S, Gazala S, Gazala S, Donahoe L, Walker K, Li C, Alnasser S, Schweigert M, Schweigert M, Zhuruk A, Hanouf A, Vanounou T, Karanicolas P, Aubin JM, Yeung J, Dumitra S, Simoneau E, Vanounou T, Howe B, Hawel J, Jang JH, Bertens K, Rekman J, Wei A, Dumitra S, Koubi S, Ouellet JF, Wei A, Covelli A, Maniar R, Sun S, Davis V, Brackstone M, Boissonneault R, Kim S, Baliski C, Gazala S, Hameed U, Sudarshan M, Arnaout A, Wedman D, Nostedt M, Hebbard P, Shetty S, Dixon M, Wei A, Dixon M, Kazazian K, Lemke M, Wells B, Musselman R, Zih FSW, Menezes A, Nassif M, Leon-Carlyle M, Wei A, Krotneva S, Bradley N, Trabulsi N, Trabulsi N, Chin-Lenn L, Cheng H, Petrucci A, Sandhu L, Neville A, Lee L, Li C, Yang I, Prabhu KL, Melich G, Knowles S, Richardson D, Borowiec A, Hallet J, Boissonneault R, Kolozsvari N, Hallet J, Tuttle P, VanHouwelingen L, Haggar F, Boulanger-Gobeil C, Chan B, Chan B, Richardson D, Musselman R, Melich G, Phang P, Goldstein L, Wen C, Lebrun A, Chadi S, Roy M, Villeneuve S, AlMuntashery A, Demyttenaere S, Christou N, Court O, Fayez R, Demyttenaere S, Christou N, Court O, Bonrath E, Hagen J, Okrainec A, Sullivan P, Grantcharov T, Sharma A, Karmali S, Birch D, Majumdar S, Wang X, Tuepah R, Klarenbach S, Birch D, Karmali S, Sharma A, Padwal R, Smith C, Haggar F, Moloo H, Poulin E, Martel G, Yelle JD, Mamazza J, Jackson T, Penner T, Pitzul K, Urbach D, Okrainec A, Villeneuve S, Roy M, Fayez R, Demyttenaere S, Christou N, Court O, Roy M, Villeneuve S, AlMuntashery A, Demyttenaere S, Christou N, Court O, Fayez R, Demyttenaere S, Court O, Christou N, Biertho L, Hould FS, Lebel S, Lescelleur O, Marceau S, Marceau P, Biron S, Grantcharov T, Sharma A, Yusuf S, Okrainec A, Pitzul K, Urbach D, Jackson T, Lindsay D, Sullivan P, Smith L, Zevin B, Dedy N, Grantcharov T, Bonrath E, Aggarwal R, Grantcharov T, Cassin S, Crawford S, Pitzul K, Khan A, Hawa R, Jackson T, Okrainec A, Brar B, Mamazza J, Raîche I, Yelle JD, Haggar F, Moloo H, Brar B, Haggar F, Dent R, Mamazza J, Raîche I, Moloo H, Gill R, Ali T, Shi X, Birch D, Karmali S, Whitlock K, Shi X, Sarkhosh K, Birch D, Karmali S, Turner J, Nation P, Wizzard P, Brubaker P, Gisalet D, Wales P, Grantcharov T, Tien H, Spencer F, Brenneman F, Kowal J, Wiseman S, Fraser S, Vedel I, Deban M, Holcroft C, Monette M, Monette J, Bergman S, Bell C, Stukel T, Urbach D, Mueller T, Lucykx V, Lukowski C, Compston C, Churchill T, Khadaroo R, Grantcharov T, Vogt K, Dubois L, Gray D, Ananth A, Tai LH, Lam T, Falls T, Souza C, Bell J, Auer R, Crawford S, Parry N, Leslie K, Alhabboubi M, St-Louis E, Deckelbaum D, Razek T, Feldman L, Khwaja K, Porter G, Johnson P, Boushey R, Moloo H, Raiche I, Mamazza J, Schiller D, Eurich D, Sawyer M, Vergis A, Unger B, Hardy K, Andrew C, Gillman L, Park J, Prodger J, Kelly W, Kelly S, Prodger D, Ewara E, Martin J, Sarma S, Chu M, Schlachta C, Zaric G, Al-Ali K, Briggs K, George R, Murnaghan M, Leung A, Regehr G, Moulton CA, Mahmud S, Metcalfe J, McKay A, Park J, Hochman D, Burkle F, Redmond A, McQueen K, Desrosiers E, Gilbert A, Leslie K, Ott M, Sudarshan M, Jessula S, Alburakan A, Deckelbaum D, Razek T, Iqbal S, Khwaja K, Aikins C, Sudarshan M, Deckelbaum D, Iqbal S, Khwaja K, Razek T, Roberts N, Moulton CA, Murnaghan M, Cil T, Marshall J, Pederson K, Erichsen S, White J, Aarts MA, Okrainec A, Victor J, Pearsall E, McLeod R, Jackson T, Okrainec A, Penner T, Urbach D, Karimuddin A, Hall C, Bawan S, Malik S, Hayashi A, Gill R, McAlister C, Zhang N, DesRosiers E, Mills A, Crozier M, Lee L, Maxwell J, Partridge E, Chad S, Steigerwald S, Mapiour D, Roberts D, MacPherson C, Donahoe L, Mercer D, Hopman W, Latulippe JF, Knowles S, Moffat B, Parry N, Leslie K, Switzer N, Khadaroo R, Tul Y, Widder S, Molinari M, Levy A, Johnson P, Bailey J, Molinari M, Hayden J, Johnson P, Benlolo S, Marcus V, Ferri L, Finley R, Anderson D, Gagné JP, Chan S, Wong S, Li J, Michael A, Choi D, Liu E, Hoogenes J, Dath D, Aubin JM, Mew D, McConnell Y, Classen D, Kanthan S, Croome K, Kovacs M, Lazo-Langner A, Hernandez-Alejandro R, Vogt K, Crawford S, Parry N, Leslie K, Khoshgoo N, Iwasiow B, Keijzer R, Brown C, Isa D, Pace D, Widder S, Tul Y, Primrose M, Hudson D, Khadaroo R, Lauzier F, Mailloux O, Trottier V, ARchambault P, Zarychanski R, Turgeon A, Mailloux O, Hardy P, Muirhead R, Masters J, Haggar F, Poulin HME, Martel G, Mamazza J, Milbrandt C, Keijzer R, Sideris L, Grenier-Vallée P, Latulippe JF, Dubé P, Kurashima Y, Kaneva P, Feldman L, Fried G, Vassiliou M, Kwan AL, Fraser S, Solymosi N, Rauh N, Dubecz A, Renz M, Ofner D, Stein H, Borgaonkar M, Crystal P, Easson A, Escallon J, Reedijk M, Cil T, Leong W, McCready D, Clifton J, Mayo J, Finley R, Noreau-Nguyen M, Mulder D, Ferri L, Markar S, Hong J, Low D, Maslow A, Davignon K, Ng T, Tan L, Aruranian J, Kosa S, Ferri L, Murphy G, Allison F, Moshonov H, Darling G, Waddell T, De Perrot M, Cypel M, Yasufuku K, Keshavjee S, Paul N, Pierre A, Darling G, Pedneault C, Marcus V, Mulder D, Ferri L, Low D, Roa W, Löbenberg R, McEwan S, Bédard E, Louie B, Farivar A, McHugh S, Aye R, Tan-Tam C, De Vera M, Bond R, Ong S, Johal B, Schellenberg D, Po M, Nissar S, Lund C, Ahmadi S, Wakil N, Rakovich G, Beauchamps G, Preston S, Baker C, Low D, Campbell G, Malthaner R, Bethune D, Henteleff H, Johnston M, Buduhan G, Coughlin HE, Roth L, Bhandari M, Malthaner R, Johnson J, Kutsogiannis J, Bédard E, Rammohan K, Stewart K, Bédard E, Buduhan G, Gruchy J, Xu Z, Buduhan G, Ferri L, Mulder D, Ncuti A, Neville A, Kaneva P, Watson D, Vassiliou M, Carli F, Feldman L, Av R, Mayrand S, Franco E, Ferri L, Dubecz A, Renz M, Stadlhuber R, Ofner D, Stein H, Renz M, Dubecz A, Solymosi N, Thumfart L, Ofner D, Stein H, Croome K, Leeper R, Hernandez R, Livingstone S, Sapp J, Woodhall D, Alwayn I, Bergman S, Lam-McCulloch J, Balaa F, Jayaraman S, Quan D, Wei A, Guyatt G, Rekman J, Fairfull-Smith R, Mimeault R, Balaa F, Martel G, Boehnert M, Bazerbachi F, Knaak J, Selzner N, McGilvray I, Rotstein O, Adeyi O, Levy G, Keshavjee S, Grant D, Selzner M, Khalil JA, Jamal M, Chaudhury P, Zogopoulos G, Petrakos P, Tchervenkov J, Barkun J, Jamal M, Hassanain M, Chaudhury P, Wong S, Salman A, Tran T, Metrakos P, Groeschl R, Geller D, Marsh J, Gamblin T, Croome K, Croome K, Quan D, Hernandez R, Kim P, Greig PD, Gallinger S, Moulton CA, Wei A, Fischer S, Cleary S, Vogt K, Hernandez-Alejandro R, Gray D, Aubin J, Fairfull-Smith J, Mimeault R, Balaa F, Martel G, Devitt K, Ramjaun A, Gallingher S, Alabbad S, Constantinos D, Hassanein M, Barkun J, Metrakos P, Paraskevas S, Chaudhury P, Tchervenkov J, Borgaonkar M, Tanyingoh D, Dixon E, Kaplan G, Myers R, Howard T, Sutherland F, Zyromski N, Ball C, Coburn N, Moulton CA, Cleary S, Law C, Greig P, Steven G, Baxter N, Fitch M, Wright F, Hochman D, Wirtzfeld D, McKay A, Yaffe C, Yip B, Silverman R, Park J, McConnell Y, Temple W, Mack L, Schiller D, Bathe O, Sawyer M, Scott L, Vandenberg T, Perera F, Potvin K, Chambers A, Loungnarath R, DeBroux É, Lavertu S, Donath D, Ayoub JP, Tehfé M, Richard C, Cornacchi S, Heller B, Farrokhyar F, Babra M, Lovrics P, Liberto C, Ghosh S, McLean R, Schiller D, Jackson T, Okrainec A, Penner T, Urbach D, Dumitra S, Duplisea J, Wexler S, Seely J, Smylie J, Knight K, Robertson S, Watters J, Zhang T, Arneout A, Hochman D, Wirtzfeld D, McKay A, Yip B, Yaffe C, Silverman R, Park J, Baxter N, Yun L, Rakovitch E, Wright F, Warner E, McCready D, Hodgson N, Quan M, Natarajan B, Govindarajan V, Thomas P, Loggie B, Brar S, Mahar A, Law C, Coburn N, Devitt K, Wiebe M, Bathe O, McLeod R, Baxter N, Gagliardi A, Kennedy E, Urbach D, Brar S, Mahar A, Law C, Coburn N, Zih F, Rosario C, Dennis J, Gingras AC, Swallow C, Ko YJ, Rowsell C, Law C, Saskin R, Quan ML, Xie M, McLaughlin K, Marginean C, Moyana T, Moloo H, Boushey R, Auer R, Razik R, Haase E, Mathieson A, Smith A, Swallow C, Barnes A, Scheer A, Moloo H, Boushey R, Sabri E, Auer R, Reidel K, Trabulsi N, Meterissian S, Tamblyn R, Mayo N, Meguerditchian A, Brown J, Hamm J, Phang P, Raval M, Brown C, Devitt K, Wiebe M, Bathe O, McLeod R, Taylor B, Urbach D, Reidel K, Mayo N, Tamblyn R, Meguerditchian A, Hamm J, Wiseman S, Patakfalvi L, Nassif M, Turcotte R, Nichols A, Meguerditchian A, Riedel K, Winslade N, Grégoire JP, Meterissian S, Abrahamovicz M, Megueerditchian A, Pasieka J, McMillan C, Lipa J, Snell L, Sudarshan M, Dumitra S, Duplisea J, Wexler S, Meterissian S, Tomlinson G, Kennedy E, Wei A, Baxter N, Urbach D, Liberman A, Charlebois P, Stein B, Ncuti A, Vassiliou M, Fried G, Feldman L, Capretti G, Power A, Liberman A, Charlebois P, Stein B, Kaneva P, Carli F, Fried G, Feldman L, Carli F, Charlebois P, Stein B, Liberman A, Kaneva P, Augustin B, Gamsa A, Kim DJ, Vassiliou M, Feldman L, Boushey R, Moloo H, Vu L, Chan S, Phang P, Gown A, Jones S, Wiseman S, Jeong DH, Hur H, Baik SH, Kim NK, Faria J, Min BS, Lumb K, Colquhoun P, Porter G, Johnson P, Baxter N, Schmocker S, Huang H, Victor J, Krzyzanowska MK, Brierley J, McLeod R, Kennedy E, Milot H, Desrosiers E, Lebrun A, Drolet S, Bouchard A, Grégoire R, Vuong T, Loungnarath R, DeBroux E, Liberman A, Charlebois P, Stein B, Richard C, Capretti G, Kaneva P, Neville A, Carli F, Liberman S, Charlebois P, Stein B, Vassiliou M, Fried G, Feldman L, Milot H, Drolet S, Bouchard A, Grégoire R, Powell R, Fowler A, Mathieson A, Martin K, Vogt K, Ott M, Pereira G, Einarsdottir K, Moloo H, Boushey R, Mamazza J, Bouchard A, Gagné J, Grégoire R, Thibault C, Bouchard P, Gomes T, Musselman R, Auer R, Moloo H, Mamdani M, Al-Omran M, Boushey R, AlObeed O, Armstrong J. Canadian Surgery Forum1 Is laparoscopic sleeve gastrectomy a reasonable stand-alone procedure for super morbidly obese patients?2 Postoperative monitoring requirements of patients with obstructive sleep apnea undergoing bariatric surgery3 Role of relaparoscopy in the diagnosis and treatment of bariatric complications in the early postoperative period4 Changes of active and total ghrelin, GLP-1 and PYY following restrictive bariatric surgery and their impact on satiety: comparison of sleeve gastrectomy and adjustable gastric banding5 Prioritization and willingness to pay for bariatric surgery: the patient perspective6 Ventral hernia at the time of laparoscopic gastric bypass surgery: Should it be repaired?7 Linear stapled gastrojejunostomy with transverse handsewn enterotomy closure significantly reduces strictures for laparoscopic Roux-en-Y bypass8 Laparoscopic biliopancreatic diversion with duodenal switch as second stage for super super morbidly obese patients. Do all patients benefit?9 Sleeve gastrectomy in the super super morbidly obese (BMI > 60 kg/m2): a Canadian experience10 Laparoscopic gastric bypass for the treatment of refractory idiopathic gastroparesis: a report of 2 cases11 Duodeno-ileal switch as a primary bariatric and metabolic surgical option for the severely obese patient with comorbidities: review of a single-institution case series of duodeno-ileal intestinal bypass12 Management of large paraesophageal hernias in morbidly obese patients with laparoscopic sleeve gastrectomy: a case series13 Early results of the Ontario bariatric surgical program: using the bariatric registry14 Improving access to bariatric surgical care: Is universal health care the answer?15 Early and liberal postoperative exploration can reduce morbidity and mortality in patients undergoing bariatric surgery16 Withdrawn17 Identification and assessment of technical errors in laparoscopic Roux-en-Y gastric bypass18 A valid and reliable tool for assessment of surgical skill in laparoscopic Roux-en-Y gastric bypass19 Psychiatric predictors of presurgery drop-out following suitability assessment for bariatric surgery20 Predictors of outcomes following Roux-en-Y gastric bypass surgery at The Ottawa Hospital21 Prophylactic management of cholelithiasis in bariatric patients: Is routine cholecystectomy warranted?22 Early outcomes of Roux-en-Y gastric bypass in a publicly funded obesity program23 Similar incidence of gastrojejunal anastomotic stricture formation with hand-sewn and 21 mm circular stapler techniques during Roux-en-Y gastric bypass24 (CAGS Basic Science Award) Exogenous glucagon-like peptide-1 improves clinical, morphological and histological outcomes of intestinal adaptation in a distal-intestinal resection piglet model of short bowel syndrome25 (CAGS Clinical Research Award) Development and validation of a comprehensive curriculum to teach an advanced minimally invasive procedure: a randomized controlled trial26 Negative-pressure wound therapy (iVAC) on closed, high-risk incisions following abdominal wall reconstruction27 The impact of seed granting on research in the University of British Columbia Department of Surgery28 Quality of surgical care is inadequate for elderly patients29 Recurrence of inguinal hernia in general and hernia specialty hospitals in Ontario, Canada30 Oncostatin M receptor deficiency results in increased mortality in an intestinal ischemia reperfusion model in mice31 Laparoscopic repair of large paraesophageal hernias with anterior gastropexy: a multicentre trial32 Response to preoperative medical therapy predicts success of laparoscopic splenectomy for immune thrombocytopenic purpura33 Perioperative sepsis, but not hemorrhagic shock, promotes the development of cancer metastases in a murine model34 Measuring the impact of implementing an acute care surgery service on the management of acute biliary disease35 Patient flow and efficiency in an acute care surgery service36 The relationship between treatment factors and postoperative complications after radical surgery for rectal cancer37 Risk of ventral hernia after laparoscopic colon surgery38 Urinary metabolomics as a tool for early detection of Barrett’s and esophageal cancer39 Construct validity of individual and summary performance metrics associated with a computer-based laparo-scopic simulator40 Impact of a city-wide health system reorganization on emergency department visits in hospitals in surrounding communities41 Transcatheter aortic valve implantation for the nonoperative management of aortic stenosis: a cost-effectiveness analysis42 Breast cancer: racial differences in age of onset. A potential confounder in Canadian screening recommendations43 Risk taking in surgery: in and out of the comfort zone44 A tumour board in the office: Track those cancer patients!45 Increased patient BMI is not associated with advanced colon cancer stage or grade on presentation: a retrospective chart review46 Consensus statements regarding the multidisciplinary care of limb amputation patients in disasters or humanitarian emergencies. Report of the 2011 Humanitarian Action Summit Surgical Working Group on amputations following disasters or conflict47 Learning the CanMEDS role of professional: a pilot project of supervised discussion groups addressing the hidden curriculum48 Assessing the changing scope of training in Canadian general surgery programs: expected versus actual experience49 Predicting need for surgical management for massive gastrointestinal hemorrhage50 International health care experience: using CanMEDS to evaluate learning outcomes following a surgical mission in Mampong, Ghana51 The open abdomen: risk factors for mortality and rates of closure52 How surgeons think: an exploration of mental practice in surgical preparation53 The surgery wiki: a novel method for delivery of under-graduate surgical education54 Understanding surgical residents’ postoperative practices before implementing an enhanced recovery after surgery (ERAS) guideline at the University of Toronto55 From laparoscopic transabdominal to posterior retroperitoneal adrenalectomy: a paradigm shift in operative approach56 A retrospective audit of outcomes in patients over the age of 80 undergoing acute care abdominal surgery57 Canadian general surgery residents’ perspectives on work-hour regulations58 Timing of surgical intervention and its outcomes in acute appendicitis59 Preparing surgical trainees to deal with adverse events. An outline of learning issues60 Acute care surgical service: surgeon agreement at the time of handover61 Predicting discharge of elderly patients to prehospitalization residence following emergency general surgery62 Morbidity and mortality after emergency abdominal surgery in octo- and nonagenarians63 The impact of acute abdominal illness and urgent admission to hospital on the living situation of elderly patients64 A comparison of laparoscopic versus open subtotal gastrectomy for antral gastric adenocarcinoma: a North American perspective65 Minimally invasive excision of ectopic mediastinal parathyroid adenomas66 Perioperative outcomes of laparoscopic hernia repair in a tertiary care centre: a single institution’s experience67 Evaluation of a student-run, practical and didactic curriculum for preclerkship medical students68 Joseph Lister: Father of Modern Surgery69 Comparisons of melanoma sentinel lymph node biopsy prediction nomograms in a cohort of Canadian patients70 Local experience with myocutaneous flaps after extensive pelvic surgery71 The treatment of noncirrhotic splanchnic vein thrombosis: Is anticoagulation enough?72 Implementation of an acute care surgery service does not affect wait-times for elective cancer surgeries: an institutional experience73 Use of human collagen mesh for closure of a large abdominal wall defect, after colon cancer surgery, a case report74 The role of miR-200b in pulmonary hypoplasia associated with congenital diaphragmatic hernia75 Systematic review and meta-analysis of electrocautery versus scalpel for incising epidermis and dermis76 Accuracy of sentinel lymph node biopsy for early breast cancer in the community setting in St. John’s, New-foundland: results of a retrospective review77 Acute surgical outcomes in the 80 plus population78 The liberal use of platelets transfusions in the acute phase of trauma resuscitation: a systematic review79 Implementation of an acute care surgical on call program in a Canadian community hospital80 Short-term outcomes following paraesophageal hernia repair in the elderly patient81 First experience with single incision surgery: feasibility in the pediatric population and cost evaluation82 The impact of the establishment of an acute care surgery unit on the outcomes of appendectomies and cholecystectomies83 Description and preliminary evaluation of a low-cost simulator for training and evaluation of flexible endoscopic skills84 Tumour lysis syndrome in metastatic colon cancer: a case report85 Acute care surgery service model implementation study at a single institution86 Colonic disasters approached by emergent subtotal and total colectomy: lessons learned from 120 consecutive cases87 Acellular collagen matrix stent to protect bowel anastomoses88 Lessons we learned from preoperative MRI-guided wire localization of breast lesions: the University Health Network (UHN) experience89 Interim cost comparison for the use of platinum micro-coils in the operative localization of small peripheral lung nodules90 Routine barium esophagram has minimal impact on the postoperative management of patients undergoing esophagectomy for esophageal cancer91 Iron deficiency anemia is a common presenting issue with giant paraesophageal hernia and resolves following repair92 A randomized comparison of different ventilation strategies during thoracotomy and lung resection93 The Canadian Lung Volume Reduction Surgery study: an 8-year follow-up94 A comparison of minimally invasive versus open Ivor-Lewis esophagectomy95 A new paradigm in the follow-up after curative resection for lung cancer: minimal-dose CT scan allows for early detection of asymptomatic cancer activity96 Predictors of lymph node metastasis in early esophageal adenocarcinoma: Is endoscopic resection worth the risk?97 How well can thoracic surgery residents operate? Comparing resident and program director opinions98 The impact of extremes of age on short- and long-term outcomes following surgical resection of esophageal malignancy99 Epidermal growth factor receptor targeted gold nanoparticles for the enhanced radiation treatment of non–small cell lung cancer100 Laparoscopic Heller myotomy results in excellent outcomes in all subtypes of achalasia as defined by the Chicago classification101 Neoadjuvant chemoradiation versus surgery in managing esophageal cancer102 Quality of life postesophagectomy for cancer!103 The implementation, evolution and translocation of standardized clinical pathways can improve perioperative outcomes following surgical treatment of esophageal cancer104 A tissue-mimicking phantom for applications in thoracic surgical simulation105 Sublobar resection compared with lobectomy for early stage non–small cell lung cancer: a single institution study106 Not all reviews are equal: the quality of systematic reviews and meta-analyses in thoracic surgery107 Do postoperative complications affect health-related quality of life after video-assisted thoracoscopic lobectomy for patients with lung cancer? A cohort study108 Thoracoscopic plication for palliation of dyspnea secondary to unilateral diaphragmatic paralysis: A worthwhile venture?109 Thoracic surgery experience in Canadian general surgery residency programs110 Perioperative morbidity and pathologic response rates following neoadjuvant chemotherapy and chemoradiation for locally advanced esophageal carcinoma111 An enhanced recovery pathway reduces length of stay after esophagectomy112 Predictors of dysplastic and neoplastic progression of Barrett’s esophagus113 Recurrent esophageal cancer complicated by tracheoesophageal fistula: management by means of palliative airway stenting114 Pancreaticopleural fistula-induced empyema thoracis: principles and results of surgical management115 Prognostic factors of early postoperative mortality following right extended hepatectomy116 Optimizing steatotic livers for transplantation using a cell-penetrating peptide CPP-fused heme oxygenase117 Video outlining the technical steps for a robot-assisted laparoscopic pancreaticoduodenectomy118 Establishment of a collaborative group to conduct innovative clinical trials in Canada119 Hepatic resection for metastatic malignant melanoma: a systematic review and meta-analysis120 Acellular normothermic ex vivo liver perfusion for donor liver preservation121 Pancreatic cancer and predictors of survival: comparing the CA 19–9/bilirubin ratio with the McGill Brisbane Scoring System122 Staged liver resections for bilobar hepatic colorectal metastases: a single centre experience123 Economic model of observation versus immediate resection of hepatic adenomas124 Resection of colorectal liver metastasis in the elderly125 Acceptable long-term survival in patients undergoing liver resection for metastases from noncolorectal, non-neuroendocrine, nonsarcoma malignancies126 Patient and clinicopathological features and prognosis of CK19+ hepatocellular carcinomas: a case–control study127 The management of blunt hepatic trauma in the age of angioembolization: a single centre experience128 Liver resections for noncolorectal and non-neuroendocrine metastases: an evaluation of oncologic outcomes129 Developing an evidence-based clinical pathway for patients undergoing pancreaticoduodenectomy130 Hepatitis C infection and hepatocellular carcinoma in liver transplant: a 20 year experience131 The effect of medication on the risk of post-ERCP pancreatitis132 Temporal trends in the use of diagnostic imaging for patients with hepato-pancreato-biliary (HPB) conditions: How much ionizing radiation are we really using?196 A phase II study of aggressive metastasectomy for intra-and extrahepatic metastases from colorectal cancer133 Why do women choose mastectomy for breast cancer treatment? A conceptual framework for understanding surgical decision-making in early-stage breast cancer134 Synoptic operative reporting: documentation of quality of care data for rectal cancer surgery135 Learning curve analysis for cytoreductive surgery: a useful application of the cumulative sum (CUSUM) method136 Pancreatic cancer is strongly associated with a unique urinary metabolomic signature137 Concurrent neoadjuvant chemo/radiation in locally advanced breast cancer138 Impact of positron emission tomography on clinical staging of newly diagnosed rectal cancer: a specialized single centre retrospective study139 An evaluation of intraoperative Faxitron microradiography versus conventional specimen radiography for the excision of nonpalpable breast lesions140 Comparison of breast cancer treatment wait-times in the Southern Interior of British Columbia in 2006 and 2010141 Factors affecting lymph nodes harvest in colorectal carcinoma142 Laparoscopic adrenalectomy for metastases143 You have a message! Social networking as a motivator for fundamentals of laparoscopic surgery (FLS) training144 The evaluation and validation of a rapid diagnostic and support clinic for women assessment for breast cancer145 Oncoplastic breast surgery: oncologic benefits and limitations146 A qualitative study on rectal cancer patients’ preferences for location of surgical care147 The effect of surgery on local recurrence in young women with breast cancer148 Elevated IL-6 and IL-8 levels in tumour microenvironment is not associated with increased serum levels in humans with Pseudomyxoma peritonei and peritoneal mesothelioma149 Conversion from laparoscopic to open approach during gastrectomy: a population-based analysis150 A scoping review of surgical process improvement tools (SPITs) in cancer surgery151 Splenectomy during gastric cancer surgery: a population-based study152 Defining the polo-like kinase 4 (Plk4) interactome in cancer cell protrusions153 Neoadjuvant imatinib mesylate for locally advanced gastrointestinal stromal tumours154 Implementing results from ACOSOG Z0011: Practice-changing or practice-affirming?155 Should lymph node retrieval be a surgical quality indicator in colon cancer?156 Long-term outcomes following resection of retroperitoneal recurrence of colorectal cancer157 Clinical research in surgical oncology: an analysis of clinicaltrials.gov158 Radiation therapy after breast conserving surgery: When are we missing the mark?159 The accuracy of endorectal ultrasound in staging rectal lesions in patients undergoing transanal endoscopic microsurgery160 Quality improvement in gastrointestinal cancer surgery: expert panel recommendations for priority research areas161 Factors influencing the quality of local management of ductal carcinoma in situ: a cohort study162 Papillary thyroid microcarcinoma: Does size matter?163 Hyperthermic isolated limb perfusion for extremity soft tissue sarcomas: systematic review of clinical efficacy and quality assessment of reported trials164 Adherence to antiestrogen therapy in seniors with breast cancer: How well are we doing?165 Parathyroid carcinoma: Challenging the surgical dogma?166 A qualitative assessment of the journey to delayed breast reconstruction195 The role of yoga therapy in breast cancer patients167 Outcomes reported in comparative studies of surgical interventions168 Enhanced recovery pathways decrease length of stay following colorectal surgery, but how quickly do patients actually recover?169 The impact of complications on bed utilization after elective colorectal resection170 Impact of trimodal prehabilitation program on functional recovery after colorectal cancer surgery: a pilot study171 Complex fistula-in-ano: Should the plug be abandoned in favour of the LIFT or BioLIFT?172 Prognostic utility of cyclooxygenase-2 expression by colon and rectal cancer173 Laparoscopic right hemicolectomy with complete mesocolic excision provides acceptable perioperative outcomes but is complex and time-consuming: analysis of learning curves for a novice minimally invasive surgeon174 Intraoperative quality assessment following double stapled circular colorectal anastomosis175 Improving patient outcomes through quality assessment of rectal cancer care176 Are physicians willing to accept a decrease in treatment effectiveness for improved functional outcomes for low rectal cancer?177 Turnbull-Cutait delayed coloanal anastomosis for the treatment of distal rectal cancer: a prospective cohort study178 Preoperative high-dose rate brachytherapy in preparation for sphincter preservation surgery for patients with advanced cancer of the lower rectum179 Impact of an enhanced recovery program on short-term outcomes after scheduled laparoscopic colon resection180 The clinical results of the Turnbull-Cutait delayed coloanal anastomosis: a systematic review181 Is a vertical rectus abdominus flap (VRAM) necessary? An analysis of perineal wound complications182 Fistula plug versus endorectal anal advancement flap for the treatment of high transsphincteric cryptoglandular anal fistulas: a systematic review and meta-analysis183 Maternal and neonatal outcomes following colorectal cancer surgery184 Transanal drainage to treat anastomotic leaks after low anterior resection for rectal cancer: a valuable option185 Trends in colon cancer in Ontario: 2002–2009186 Validation of electronically derived short-term outcomes in colorectal surgery187 A population-based assessment of transanal and endoscopic resection for adenocarcinoma of the rectum188 Laparoscopic colorectal surgery in the emergency setting: trends in the province of Ontario from 2002 to 2009189 Prevention of perineal hernia after laparoscopic and robotic abdominoperineal resection: review with case series of internal hernia through pelvic mesh which was placed in attempt to prevent perineal hernia190 Effect of rectal cancer treatments on quality of life191 The use of antibacterial sutures as an adjunctive preventative strategy for surgical site infection in Canada: an economic analysis192 Impact of socioeconomic status on colorectal cancer screening and stage at presentation: preliminary results of a population-based study from an urban Canadian centre193 Initial perioperative results of the first transanal endoscopic microsurgery (TEM) program in the province of Quebec194 Use of negative pressure wound therapy decreases perineal wound infections following abdominal perineal resection. Can J Surg 2012; 55:S63-S135. [DOI: 10.1503/cjs.016712] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
43
|
Cravo A, Pereira C, Gomes T, Cardoso C, Serafim A, Almeida C, Rocha T, Lopes B, Company R, Medeiros A, Norberto R, Pereira R, Araújo O, Bebianno MJ. A multibiomarker approach in the clam Ruditapes decussatus to assess the impact of pollution in the Ria Formosa lagoon, South Coast of Portugal. Mar Environ Res 2012; 75:23-34. [PMID: 22001190 DOI: 10.1016/j.marenvres.2011.09.012] [Citation(s) in RCA: 66] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/24/2011] [Revised: 09/22/2011] [Accepted: 09/23/2011] [Indexed: 05/31/2023]
Abstract
The Ria Formosa lagoon is an ecosystem whose water quality reflects the anthropogenic influence upon the surrounding areas. In this lagoon, the clam Ruditapes decussatus has a great economical importance and has been widely used as a biomonitor. A multibiomarker approach (δ-aminolevulinic acid dehydratase, metallothionein, lipid peroxidation, acetylcholinesterase, alkali-labile phosphates, DNA damage) was applied to assess the environmental quality of this ecosystem and the accumulation of contaminants and their potential adverse effects on clams. Clams were sampled in different shellfish beds in the period between July 2007 and December 2008 and abiotic parameters (temperature, salinity, pH and dissolved oxygen of seawater and organic matter in the sediment), condition index, metals (Cd, Cu, Zn, Ni, Pb), TBTs and PAHs concentrations were measured in clam tissues. Data was integrated using Principal Component Analyses and biomarker indices: IBR (Integrated Biomarker Response) and HSI (Health Status Index). This multibiomarker approach enabled discrimination of a time and space trend between sites with different degrees of anthropogenic contamination, identifying one of them (site 2) as the most stressful and summer months as the most critical period for clams due to an increase of environmental stress (anthropogenic pressure along with extreme environmental conditions, e.g. temperature, dissolved oxygen, organic matter in the sediments, etc). The selected biomarkers provided an integrated response to assess the environmental quality of the system, proving to be a useful approach when complex mixtures of contaminants occur.
Collapse
Affiliation(s)
- A Cravo
- CIMA-Centre for Marine and Environmental Research, Faculty of Sciences and Technology (FCT), University of Algarve, Campus de Gambelas, 8005-139 Faro, Portugal
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
44
|
Chiu JC, Shi X, Karmali S, Birch DW, Apriasz I, Alkhamesi NA, Lal A, Schlachta CM, Christou NV, Elkassem S, Lindsay D, Smith L, Sullivan P, Sockalingam S, Hawa R, Wnuk S, Jackson T, Okrainec A, Fayez R, Christou NV, Court O, Mueller C, Okrainec A, Sockalingham S, Jackson T, Mueller C, Swanson T, Daigle C, Okrainec A, Pitzul K, Penner T, Urbach DR, Jackson T, Sandhu L, Maciver A, McCall M, Edgar R, Thiesen A, Bigam D, Churchill T, Shapiro AMJ, Luu S, Regehr G, Murnaghan ML, Gallinger S, Moulton CA, Palter V, Grantcharov T, Dath D, Hoogenes J, Matsumoto E, Szalay D, Fox A, Pitzul K, Bhojani F, Kaplan M, Wei A, McGilvray I, Cleary SP, Okrainec A, Alqahtani A, Parsyan A, Payne R, Tabah R, Anantha R, Vogt K, Crawford S, Parry N, Leslie K, Ochs A, Matthew K, Khadaroo R, Churchill T, Lavoie JM, Zalai C, Vasilevsky CA, Booy J, Takata J, Tomlinson G, Urbach DR, Lim D, Tomlinson C, LaBossiere J, Rommens K, Birch DW, Brenneman F, MacLellan S, Simpson J, Asai K, Elgadi K, Ali S, Sawyer J, Helewa R, Turner D, Wirtzfeld D, Park J, Czaykowski P, Mak G, Hochman D, McKay A, Gill R, Al-Adra D, Shi X, Sample C, Armstrong J, Lester L, Vogt K, Brackstone M, Lee L, Kaneva P, Liberman S, Charlebois P, Stein B, Fried G, Feldman L, Kanji A, Sharon E, Asai K, Jacks L, McCready D, Ghazarian D, Leong WL, Wu R, Okrainec A, Penner T, Ball C, Kirkpatrick A, Vasquez A, Balakrishnan L, Miller G, Awan S, Azadeh NR, Hoogenes J, Dath D, Jain V, Busato GM, Cristea O, Landau J, Moreland R, Johnson M, Ramage D, Browning D, Ullah S, Cristea O, Bodrogi A, Johnson M, McAlister V, Palisoc J, Anderson J, Kiladze R, Ciar J, Bancel I, Pitzul K, Leake PA, Okrainec A, Dalvi A, McLean R, Stephen W, Loeb M, Smith R, Christoffersen E, Forbes S, Kidane B, Vogt K, Vinden C, Ahmadi N, Dubois L, McKenzie M, Baxter N, Brown C, Chaudhury P, Dixon E, Fitzgerald W, Henteleff H, Kirkpatrick A, Latosinsky S, MacLean A, McLeod R, Pearsall E, Aarts MA, Meghji Z, McLeod R, Okrainec A, Tran T, Kaneva P, Fried G, Mayo N, Feldman L, Newman D, Bergman S, Cummings BA, Delisle M, Whitehead V, Chertkow H, Chan T, Cicero M, Perampaladas K, Bandukwala T, Struble J, Moser M, Young P, Groeneveld A, Chan P, Smith S, Khadaroo R, Buczkowski A, Hameed M, Tan-Tam C, Meneghetti A, Simons R, Panton N, Elnahas A, Ghaderi I, Madani A, de Gara C, Schlachta CM, Kalechstein S, Pitzul K, Henao O, Okrainec A, Paskar D, Croome K, Hernandez R, Knapp G, Howatt N, Foster S, Cameron B, Austin J, Mack L, Temple W, Puloski S, Schachar N, Gill T, Doris P, Tecson A, Kolozsvari N, Andalib A, Kaneva P, Cao J, Vassiliou M, Fried G, Feldman L, Kolozsvari N, Kaneva P, Vassiliou M, Fried G, Feldman L, Kolozsvari N, Kaneva P, Brace C, Chartrand G, Vaillancourt M, Cao J, Banaszek D, Vassiliou M, Fried G, Feldman L, Fraser S, Bergman S, Deobald R, Chad J, Di Gregorio C, Johnstone J, Kenyon C, Lees M, Auger-Dufour E, Fried G, Feldman L, Ferri L, Vassiliou M, Alqahtani A, Perlman R, Holcroft C, Gordon PH, Szilagyi A, Iradukunda D, Moser MAJ, Rodych N, Shaw JM, Ahmed N, Chiu M, Kurabi B, Qureshi A, Nathens A, Conn LG, Pandya A, Kitto S, Ma G, Pooni A, Forbes S, Eskicioglu C, Pearsall E, Brenneman F, McLeod R, Rockx MA, McAlister V, Roberts D, Ouellet J, Kirkpatrick A, Lall R, Sutherland F, Ball C, Chackungal S, Knowlton LM, Dahn B, McQueen K, Morrison JA, Lent B, Brown J, Fluit M, Herbert C, Deen S, Deutschmann M, McFadden S, Gelfand G, Bosch D, Grimmer L, Milman S, Ng T, Gill R, Perry T, Abele J, Bedard E, Schiller D, Coughlin S, Stewart TC, Parry N, Gray D, Williamson J, Malthaner R, Bottoni D, Perri M, Trejos AL, Naish M, Patel R, Malthaner R, Ashrafi A, Bond J, Ong S, Yamashita M, Ahmadi S, Abdulmosen M, Miller J, Finley C, Ostrander K, Shargall Y, Lee L, Hanley S, Robineau C, Sirois C, Mulder D, Ferri L, Humphrey R, Inculet R, Fortin D, Arab A, Malthaner R, Ashrafi A, Bond J, Ong S, Yamashita M, Ahmadi S, McGuire A, Reid K, Petsikas D, Hopman W, Basi A, Basi S, Irshad K, Hanna W, Croome KP, Marotta P, McAlister V, Quan D, Wall W, Hernandez-Alejandro R, de Mestral C, Zagorski B, Rotstein O, Gomez D, Haas B, Laupacis A, Sharma S, Bridge J, Nathens A, Bhojani F, Fox A, Pitzul K, Moulton CA, Wei A, Okrainec A, Cleary S, Bertens K, Croome KP, Mujoomdar A, Peck D, Rankin R, Quan D, Kakani N, Hernandez-Alejandro R, Suri R, Marcaccio M, Ruo L, Jamal M, Khalil JA, Simoneau-Beaudry E, Dumitra S, Edwards M, Yousef Y, Jiffry MA, Metrakos P, Tchervenkov J, Doi S, Barkun J, Obayan A, Meiers S, Keith R, Elkassem S, Church N, Mitchell P, Turbide C, Dixon E, Debru E, Shum J, Wall WJ, Maniar R, Hochman D, Wirtzfeld D, Yaffe C, Yip B, McKay A, Silverman R, Park J, Francescutti V, Rivera L, Kane JM, Skitzki JJ, Lovrics P, Hodgson N, O'Brien MA, Thabane L, Cornacchi S, Heller B, Reid S, Sanders K, Kittmer T, Simunovic M, Duhaime S, Fong B, Deria M, Acton C, El-Maadawy M, Lad S, Arnaout A, Omole M, Pemberton J, Lovrics P, Bischof D, Stotland P, Hagen J, Swallow C, Klein L, Van Koughnett JA, Ahmad T, Ainsworth P, Brackstone M, Kanagaratnam S, Groot G, VanderBeek L, Francescutti V, Farrokhyar F, Strang B, Kahnamoui K, MacLellan S, MacKay H, Ringash J, Jacks L, Kassam Z, Khalili I, Conrad T, Okrainec A, Chagpar R, Xing Y, You N, Yi-Ju C, Feig B, Chang G, Cormie J, Gervais MK, Sideris L, Drolet P, Mitchell A, Leblanc G, Dubé P, Merchant S, Knowling M, Cheifetz R, Raval M, Heidary B, Kalikias S, Raval D, Phang T, Brown C, Scheer A, O'Connor A, Chan B, Moloo H, Poulin E, Mamazza J, Auer R, Boushey R, Hardy K, Vergis A, Sullivan P, Musselman R, Gomes T, Chan B, Auer R, Moloo H, Poulin E, Mamazza J, Al-Khayal K, Al-Omran M, Mamdani M, AlObeed O, Boushey R, Martel G, Crawford A, Barkun J, Ramsay C, Fergusson D, Boushey R, Williams L, Crawford A, McLaughlin K, Mackey M, Moloo H, Mamazza J, Poulin E, Friedlich M, Boushey R, Auer R, Bellolio F, Cohen Z, MacRae H, O'Connor B, Huang H, Victor JC, McLeod R, Hardy K, Pitzul K, Kwong J, Vergis A, Urbach D, Okrainec A, Vogt K, Dubois L, Vinden C, Chan B, Scheer A, Menezes A, Moloo H, Poulin E, Boushey R, Mamazza J, Bellolio F, MacRae H, Cohen Z, O'Connor B, Huang H, McLeod R, Godbout-Simard C, Azar J, Psaradellis F, Sampalis J, Morin N, Brown C, Kalikias S, Heidary B, Raval D, Phang PT, Raval M, Archibald A, Hurlbut D, Vanner S, Zalai C, Vasilevsky CA, Simunovic M, Cadeddu M, Forbes S, Kelly S, Stephen W, Grubac V, Marcinow M, Coates A, Aslani N, Phang PT, Raval M, Brown C, Scheer A, Carrier M, Boushey R, Asmis T, Wells P, Jonker D, Auer R, Azer N, Gill R, de Gara C, Birch DW, Karmali S, Roxin G, Drolet S, MacLean A, Buie WD, Heine J, Agzarian J, Forbes S, Stephen W, Kelly S, Churchill P, Corner T, Kelly S, Forbes S, Lindsay L, Stephen W, Scheer A, O'Connor A, Chan B, Moloo H, Poulin E, Mamazza J, Auer R, Boushey R, Denis J, Hochman D, Recsky M, Phang PT, Raval M, Cheung W, Brown C, Alkhamesi N, Schlachta CM, Tiwari T, Brown C, Raval MJ, Phang PT. Canadian Surgery Forum: Abstracts of presentations to the Annual Meetings of the Canadian Association of Bariatric Physicians and Surgeons, Canadian Association of General Surgeons, Canadian Association of Thoracic Surgeons, Canadian Hepato-Pancreato-Biliary Society, Canadian Society of Surgical Oncology, Canadian Society of Colon and Rectal Surgeons, London, Ont. Sept. 15-18, 2011. Can J Surg 2011; 54:S57-S104. [PMID: 35488394 PMCID: PMC3191910] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/14/2023] Open
Affiliation(s)
- J C Chiu
- From the University of Alberta, Royal Alexandra Hospital, Edmonton, Alta
| | - X Shi
- From the University of Alberta, Royal Alexandra Hospital, Edmonton, Alta
| | - S Karmali
- From the University of Alberta, Royal Alexandra Hospital, Edmonton, Alta
| | - D W Birch
- From the University of Alberta, Royal Alexandra Hospital, Edmonton, Alta
| | - I Apriasz
- From the Schulich School of Medicine and Dentistry and the London Health Sciences Centre, London, Ont
| | - N A Alkhamesi
- From the Schulich School of Medicine and Dentistry and the London Health Sciences Centre, London, Ont
| | - A Lal
- From the Schulich School of Medicine and Dentistry and the London Health Sciences Centre, London, Ont
| | - C M Schlachta
- From the Schulich School of Medicine and Dentistry and the London Health Sciences Centre, London, Ont
| | | | - S Elkassem
- From the University of Toronto, Toronto, Ont
| | - D Lindsay
- From the University of Toronto, Toronto, Ont
| | - L Smith
- From the University of Toronto, Toronto, Ont
| | - P Sullivan
- From the University of Toronto, Toronto, Ont
| | - S Sockalingam
- From the University Health Network, Toronto Western Hospital, University of Toronto, Toronto, Ont
| | - R Hawa
- From the University Health Network, Toronto Western Hospital, University of Toronto, Toronto, Ont
| | - S Wnuk
- From the University Health Network, Toronto Western Hospital, University of Toronto, Toronto, Ont
| | - T Jackson
- From the University Health Network, Toronto Western Hospital, University of Toronto, Toronto, Ont
| | - A Okrainec
- From the University Health Network, Toronto Western Hospital, University of Toronto, Toronto, Ont
| | - R Fayez
- From the McGill University Health Centre, Montréal, Que
| | - N V Christou
- From the McGill University Health Centre, Montréal, Que
| | - O Court
- From the McGill University Health Centre, Montréal, Que
| | - C Mueller
- From the Division of General Surgery and Division of Psychiatry, University Health Network, Department of Surgery, University of Toronto, Toronto, Ont
| | - A Okrainec
- From the Division of General Surgery and Division of Psychiatry, University Health Network, Department of Surgery, University of Toronto, Toronto, Ont
| | - S Sockalingham
- From the Division of General Surgery and Division of Psychiatry, University Health Network, Department of Surgery, University of Toronto, Toronto, Ont
| | - T Jackson
- From the Division of General Surgery and Division of Psychiatry, University Health Network, Department of Surgery, University of Toronto, Toronto, Ont
| | - C Mueller
- From the Division of General Surgery, University Health Network, Department of Surgery, University of Toronto, Toronto, Ont
| | - T Swanson
- From the Division of General Surgery, University Health Network, Department of Surgery, University of Toronto, Toronto, Ont
| | - C Daigle
- From the Division of General Surgery, University Health Network, Department of Surgery, University of Toronto, Toronto, Ont
| | - A Okrainec
- From the Division of General Surgery, University Health Network, Department of Surgery, University of Toronto, Toronto, Ont
| | - K Pitzul
- From the Division of General Surgery, University Health Network, Department of Surgery, University of Toronto, Toronto, Ont
| | - T Penner
- From the Division of General Surgery, University Health Network, Department of Surgery, University of Toronto, Toronto, Ont
| | - D R Urbach
- From the Division of General Surgery, University Health Network, Department of Surgery, University of Toronto, Toronto, Ont
| | - T Jackson
- From the Division of General Surgery, University Health Network, Department of Surgery, University of Toronto, Toronto, Ont
| | - L Sandhu
- From the University of Toronto, Toronto, Ont
| | - A Maciver
- From the University of Alberta, Edmonton, Alta
| | - M McCall
- From the University of Alberta, Edmonton, Alta
| | - R Edgar
- From the University of Alberta, Edmonton, Alta
| | - A Thiesen
- From the University of Alberta, Edmonton, Alta
| | - D Bigam
- From the University of Alberta, Edmonton, Alta
| | - T Churchill
- From the University of Alberta, Edmonton, Alta
| | | | - S Luu
- From the Wilson Centre, University Health Network, Department of Surgery, University of Toronto, Hospital for Sick Children, Toronto, Ont., and the Centre for Health Education Scholarship, University of British Columbia, Vancouver, BC
| | - G Regehr
- From the Wilson Centre, University Health Network, Department of Surgery, University of Toronto, Hospital for Sick Children, Toronto, Ont., and the Centre for Health Education Scholarship, University of British Columbia, Vancouver, BC
| | - M L Murnaghan
- From the Wilson Centre, University Health Network, Department of Surgery, University of Toronto, Hospital for Sick Children, Toronto, Ont., and the Centre for Health Education Scholarship, University of British Columbia, Vancouver, BC
| | - S Gallinger
- From the Wilson Centre, University Health Network, Department of Surgery, University of Toronto, Hospital for Sick Children, Toronto, Ont., and the Centre for Health Education Scholarship, University of British Columbia, Vancouver, BC
| | - C-A Moulton
- From the Wilson Centre, University Health Network, Department of Surgery, University of Toronto, Hospital for Sick Children, Toronto, Ont., and the Centre for Health Education Scholarship, University of British Columbia, Vancouver, BC
| | - V Palter
- From St. Michael's Hospital, University of Toronto, Toronto, Ont
| | - T Grantcharov
- From St. Michael's Hospital, University of Toronto, Toronto, Ont
| | - D Dath
- From McMaster University, Hamilton, Ont
| | | | | | - D Szalay
- From McMaster University, Hamilton, Ont
| | - A Fox
- From University of Toronto, Toronto Western Hospital, Toronto, Ont
| | - K Pitzul
- From University of Toronto, Toronto Western Hospital, Toronto, Ont
| | - F Bhojani
- From University of Toronto, Toronto Western Hospital, Toronto, Ont
| | - M Kaplan
- From University of Toronto, Toronto Western Hospital, Toronto, Ont
| | - A Wei
- From University of Toronto, Toronto Western Hospital, Toronto, Ont
| | - I McGilvray
- From University of Toronto, Toronto Western Hospital, Toronto, Ont
| | - S P Cleary
- From University of Toronto, Toronto Western Hospital, Toronto, Ont
| | - A Okrainec
- From University of Toronto, Toronto Western Hospital, Toronto, Ont
| | | | - A Parsyan
- From McGill University, Montréal, Que
| | - R Payne
- From McGill University, Montréal, Que
| | - R Tabah
- From McGill University, Montréal, Que
| | - R Anantha
- From the Division of General Surgery, Victoria Hospital, London Health Sciences Centre, University of Western Ontario, London, Ont
| | - K Vogt
- From the Division of General Surgery, Victoria Hospital, London Health Sciences Centre, University of Western Ontario, London, Ont
| | - S Crawford
- From the Division of General Surgery, Victoria Hospital, London Health Sciences Centre, University of Western Ontario, London, Ont
| | - N Parry
- From the Division of General Surgery, Victoria Hospital, London Health Sciences Centre, University of Western Ontario, London, Ont
| | - K Leslie
- From the Division of General Surgery, Victoria Hospital, London Health Sciences Centre, University of Western Ontario, London, Ont
| | - A Ochs
- From the University of Alberta, Edmonton, Alta
| | - K Matthew
- From the University of Alberta, Edmonton, Alta
| | - R Khadaroo
- From the University of Alberta, Edmonton, Alta
| | - T Churchill
- From the University of Alberta, Edmonton, Alta
| | | | - C Zalai
- From McGill University, Montréal, Que
| | | | - J Booy
- From the University Health Network, Toronto, Ont
| | - J Takata
- From the University Health Network, Toronto, Ont
| | - G Tomlinson
- From the University Health Network, Toronto, Ont
| | - D R Urbach
- From the University Health Network, Toronto, Ont
| | - D Lim
- From the University of Alberta, Edmonton, Alta
| | - C Tomlinson
- From the University of Alberta, Royal Alexandra Hospital, Edmonton, Alta
| | - J LaBossiere
- From the University of Alberta, Royal Alexandra Hospital, Edmonton, Alta
| | - K Rommens
- From the University of Alberta, Royal Alexandra Hospital, Edmonton, Alta
| | - D W Birch
- From the University of Alberta, Royal Alexandra Hospital, Edmonton, Alta
| | - F Brenneman
- From Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont
| | - S MacLellan
- From Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont
| | - J Simpson
- From Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont
| | - K Asai
- From Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont
| | - K Elgadi
- From Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont
| | - S Ali
- From Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont
| | - J Sawyer
- From Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont
| | - R Helewa
- From the University of Manitoba, CancerCare Manitoba, Winnipeg, Man
| | - D Turner
- From the University of Manitoba, CancerCare Manitoba, Winnipeg, Man
| | - D Wirtzfeld
- From the University of Manitoba, CancerCare Manitoba, Winnipeg, Man
| | - J Park
- From the University of Manitoba, CancerCare Manitoba, Winnipeg, Man
| | - P Czaykowski
- From the University of Manitoba, CancerCare Manitoba, Winnipeg, Man
| | - G Mak
- From the University of Manitoba, CancerCare Manitoba, Winnipeg, Man
| | - D Hochman
- From the University of Manitoba, CancerCare Manitoba, Winnipeg, Man
| | - A McKay
- From the University of Manitoba, CancerCare Manitoba, Winnipeg, Man
| | - R Gill
- From the University of Alberta, Edmonton, Alta
| | - D Al-Adra
- From the University of Alberta, Edmonton, Alta
| | - X Shi
- From the University of Alberta, Edmonton, Alta
| | - C Sample
- From the University of Alberta, Edmonton, Alta
| | - J Armstrong
- From the University of Western Ontario, London, Ont
| | - L Lester
- From the University of Western Ontario, London, Ont
| | - K Vogt
- From the University of Western Ontario, London, Ont
| | - M Brackstone
- From the University of Western Ontario, London, Ont
| | - L Lee
- From the McGill University Health Centre, Montréal, Que
| | - P Kaneva
- From the McGill University Health Centre, Montréal, Que
| | - S Liberman
- From the McGill University Health Centre, Montréal, Que
| | - P Charlebois
- From the McGill University Health Centre, Montréal, Que
| | - B Stein
- From the McGill University Health Centre, Montréal, Que
| | - G Fried
- From the McGill University Health Centre, Montréal, Que
| | - L Feldman
- From the McGill University Health Centre, Montréal, Que
| | - A Kanji
- From the University of Toronto, University Health Network, Toronto, Ont
| | - E Sharon
- From the University of Toronto, University Health Network, Toronto, Ont
| | - K Asai
- From the University of Toronto, University Health Network, Toronto, Ont
| | - L Jacks
- From the University of Toronto, University Health Network, Toronto, Ont
| | - D McCready
- From the University of Toronto, University Health Network, Toronto, Ont
| | - D Ghazarian
- From the University of Toronto, University Health Network, Toronto, Ont
| | - W-L Leong
- From the University of Toronto, University Health Network, Toronto, Ont
| | - R Wu
- From The Ottawa Hospital, Ottawa and Toronto Western Hospital, Toronto, Ont
| | - A Okrainec
- From The Ottawa Hospital, Ottawa and Toronto Western Hospital, Toronto, Ont
| | - T Penner
- From The Ottawa Hospital, Ottawa and Toronto Western Hospital, Toronto, Ont
| | - C Ball
- From the University of Calgary, Calgary, Alta
| | | | - A Vasquez
- From the University of Saskatchewan, Saskatoon, Sask
| | | | - G Miller
- From the University of Saskatchewan, Saskatoon, Sask
| | - S Awan
- From the University of Saskatchewan, Saskatoon, Sask
| | | | | | - D Dath
- From McMaster University, Hamilton, Ont
| | - V Jain
- From the University of Western Ontario, London, Ont
| | - G-M Busato
- From the Schulich School of Medicine and Dentistry, and Canadian Surgical Technologies and Advanced Robotics, London, Ont
| | - O Cristea
- From the Schulich School of Medicine and Dentistry, and Canadian Surgical Technologies and Advanced Robotics, London, Ont
| | - J Landau
- From the Schulich School of Medicine and Dentistry, and Canadian Surgical Technologies and Advanced Robotics, London, Ont
| | - R Moreland
- From the Schulich School of Medicine and Dentistry, and Canadian Surgical Technologies and Advanced Robotics, London, Ont
| | - M Johnson
- From the Schulich School of Medicine and Dentistry, and Canadian Surgical Technologies and Advanced Robotics, London, Ont
| | - D Ramage
- From the Schulich School of Medicine and Dentistry, and Canadian Surgical Technologies and Advanced Robotics, London, Ont
| | - D Browning
- From the Schulich School of Medicine and Dentistry, and Canadian Surgical Technologies and Advanced Robotics, London, Ont
| | - S Ullah
- From the Canadian Forces Medical Service and University of Western Ontario, London, Ont
| | - O Cristea
- From the Canadian Forces Medical Service and University of Western Ontario, London, Ont
| | - A Bodrogi
- From the Canadian Forces Medical Service and University of Western Ontario, London, Ont
| | - M Johnson
- From the Canadian Forces Medical Service and University of Western Ontario, London, Ont
| | - V McAlister
- From the Canadian Forces Medical Service and University of Western Ontario, London, Ont
| | - J Palisoc
- From the Division of General Surgery, University Health Network, University of Toronto, Toronto, Ont
| | - J Anderson
- From the Division of General Surgery, University Health Network, University of Toronto, Toronto, Ont
| | - R Kiladze
- From the Division of General Surgery, University Health Network, University of Toronto, Toronto, Ont
| | - J Ciar
- From the Division of General Surgery, University Health Network, University of Toronto, Toronto, Ont
| | - I Bancel
- From the Division of General Surgery, University Health Network, University of Toronto, Toronto, Ont
| | - K Pitzul
- From the Division of General Surgery, University Health Network, University of Toronto, Toronto, Ont
| | - P-A Leake
- From the Division of General Surgery, University Health Network, University of Toronto, Toronto, Ont
| | - A Okrainec
- From the Division of General Surgery, University Health Network, University of Toronto, Toronto, Ont
| | - A Dalvi
- From the Department of Surgery, Department of Pathology and Molecular Medicine, McMaster University and Hamilton Health Sciences Hamilton, Ont
| | - R McLean
- From the Department of Surgery, Department of Pathology and Molecular Medicine, McMaster University and Hamilton Health Sciences Hamilton, Ont
| | - W Stephen
- From the Department of Surgery, Department of Pathology and Molecular Medicine, McMaster University and Hamilton Health Sciences Hamilton, Ont
| | - M Loeb
- From the Department of Surgery, Department of Pathology and Molecular Medicine, McMaster University and Hamilton Health Sciences Hamilton, Ont
| | - R Smith
- From the Department of Surgery, Department of Pathology and Molecular Medicine, McMaster University and Hamilton Health Sciences Hamilton, Ont
| | - E Christoffersen
- From the Department of Surgery, Department of Pathology and Molecular Medicine, McMaster University and Hamilton Health Sciences Hamilton, Ont
| | - S Forbes
- From the Department of Surgery, Department of Pathology and Molecular Medicine, McMaster University and Hamilton Health Sciences Hamilton, Ont
| | - B Kidane
- From the University of Western Ontario, London, Ont
| | - K Vogt
- From the University of Western Ontario, London, Ont
| | - C Vinden
- From the University of Western Ontario, London, Ont
| | - N Ahmadi
- From the University of Toronto, Toronto, the University of Western Ontario, London, Ont., the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC, McGill University, Montréal, Que., the University of Calgary, Calgary, Alta., Charles S. Curtis Memorial Hospital, St. Anthony, NL, and Dalhousie University, Halifax, NS
| | - L Dubois
- From the University of Toronto, Toronto, the University of Western Ontario, London, Ont., the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC, McGill University, Montréal, Que., the University of Calgary, Calgary, Alta., Charles S. Curtis Memorial Hospital, St. Anthony, NL, and Dalhousie University, Halifax, NS
| | - M McKenzie
- From the University of Toronto, Toronto, the University of Western Ontario, London, Ont., the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC, McGill University, Montréal, Que., the University of Calgary, Calgary, Alta., Charles S. Curtis Memorial Hospital, St. Anthony, NL, and Dalhousie University, Halifax, NS
| | - N Baxter
- From the University of Toronto, Toronto, the University of Western Ontario, London, Ont., the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC, McGill University, Montréal, Que., the University of Calgary, Calgary, Alta., Charles S. Curtis Memorial Hospital, St. Anthony, NL, and Dalhousie University, Halifax, NS
| | - C Brown
- From the University of Toronto, Toronto, the University of Western Ontario, London, Ont., the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC, McGill University, Montréal, Que., the University of Calgary, Calgary, Alta., Charles S. Curtis Memorial Hospital, St. Anthony, NL, and Dalhousie University, Halifax, NS
| | - P Chaudhury
- From the University of Toronto, Toronto, the University of Western Ontario, London, Ont., the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC, McGill University, Montréal, Que., the University of Calgary, Calgary, Alta., Charles S. Curtis Memorial Hospital, St. Anthony, NL, and Dalhousie University, Halifax, NS
| | - E Dixon
- From the University of Toronto, Toronto, the University of Western Ontario, London, Ont., the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC, McGill University, Montréal, Que., the University of Calgary, Calgary, Alta., Charles S. Curtis Memorial Hospital, St. Anthony, NL, and Dalhousie University, Halifax, NS
| | - W Fitzgerald
- From the University of Toronto, Toronto, the University of Western Ontario, London, Ont., the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC, McGill University, Montréal, Que., the University of Calgary, Calgary, Alta., Charles S. Curtis Memorial Hospital, St. Anthony, NL, and Dalhousie University, Halifax, NS
| | - H Henteleff
- From the University of Toronto, Toronto, the University of Western Ontario, London, Ont., the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC, McGill University, Montréal, Que., the University of Calgary, Calgary, Alta., Charles S. Curtis Memorial Hospital, St. Anthony, NL, and Dalhousie University, Halifax, NS
| | - A Kirkpatrick
- From the University of Toronto, Toronto, the University of Western Ontario, London, Ont., the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC, McGill University, Montréal, Que., the University of Calgary, Calgary, Alta., Charles S. Curtis Memorial Hospital, St. Anthony, NL, and Dalhousie University, Halifax, NS
| | - S Latosinsky
- From the University of Toronto, Toronto, the University of Western Ontario, London, Ont., the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC, McGill University, Montréal, Que., the University of Calgary, Calgary, Alta., Charles S. Curtis Memorial Hospital, St. Anthony, NL, and Dalhousie University, Halifax, NS
| | - A MacLean
- From the University of Toronto, Toronto, the University of Western Ontario, London, Ont., the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC, McGill University, Montréal, Que., the University of Calgary, Calgary, Alta., Charles S. Curtis Memorial Hospital, St. Anthony, NL, and Dalhousie University, Halifax, NS
| | - R McLeod
- From the University of Toronto, Toronto, the University of Western Ontario, London, Ont., the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC, McGill University, Montréal, Que., the University of Calgary, Calgary, Alta., Charles S. Curtis Memorial Hospital, St. Anthony, NL, and Dalhousie University, Halifax, NS
| | - E Pearsall
- From the University of Toronto, Toronto, Ont
| | - M-A Aarts
- From the University of Toronto, Toronto, Ont
| | - Z Meghji
- From the University of Toronto, Toronto, Ont
| | - R McLeod
- From the University of Toronto, Toronto, Ont
| | - A Okrainec
- From the University of Toronto, Toronto, Ont
| | - T Tran
- From McGill University, Montréal, Que
| | - P Kaneva
- From McGill University, Montréal, Que
| | - G Fried
- From McGill University, Montréal, Que
| | - N Mayo
- From McGill University, Montréal, Que
| | - L Feldman
- From McGill University, Montréal, Que
| | - D Newman
- From McGill University and the Jewish General Hospital, Montréal, Que
| | - S Bergman
- From McGill University and the Jewish General Hospital, Montréal, Que
| | - B-A Cummings
- From McGill University and the Jewish General Hospital, Montréal, Que
| | - M Delisle
- From McGill University and the Jewish General Hospital, Montréal, Que
| | - V Whitehead
- From McGill University and the Jewish General Hospital, Montréal, Que
| | - H Chertkow
- From McGill University and the Jewish General Hospital, Montréal, Que
| | - T Chan
- From McMaster University, Hamilton, Ont
| | - M Cicero
- From McMaster University, Hamilton, Ont
| | | | | | - J Struble
- From the Department of Surgery, University of Saskatchewan, Saskatoon, Sask
| | - M Moser
- From the Department of Surgery, University of Saskatchewan, Saskatoon, Sask
| | - P Young
- From the University of Alberta, Edmonton, Alta
| | | | - P Chan
- From the University of Alberta, Edmonton, Alta
| | - S Smith
- From the University of Alberta, Edmonton, Alta
| | - R Khadaroo
- From the University of Alberta, Edmonton, Alta
| | - A Buczkowski
- From the University of British Columbia, Vancouver, BC
| | - M Hameed
- From the University of British Columbia, Vancouver, BC
| | - C Tan-Tam
- From the University of British Columbia, Vancouver, BC
| | - A Meneghetti
- From the University of British Columbia, Vancouver, BC
| | - R Simons
- From the University of British Columbia, Vancouver, BC
| | - N Panton
- From the University of British Columbia, Vancouver, BC
| | - A Elnahas
- From McMaster University, Hamilton, Ont
| | - I Ghaderi
- From the University of Western Ontario, London, Ont., and the University of Alberta, Edmonton, Alta
| | - A Madani
- From the University of Western Ontario, London, Ont., and the University of Alberta, Edmonton, Alta
| | - C de Gara
- From the University of Western Ontario, London, Ont., and the University of Alberta, Edmonton, Alta
| | - C M Schlachta
- From the University of Western Ontario, London, Ont., and the University of Alberta, Edmonton, Alta
| | - S Kalechstein
- From McMaster University, Hamilton University Health Network, Hamilton, University of Toronto, Toronto, Ont., and the Hospital Universitario San Vicente Fundacion, Medellin, Colombia
| | - K Pitzul
- From McMaster University, Hamilton University Health Network, Hamilton, University of Toronto, Toronto, Ont., and the Hospital Universitario San Vicente Fundacion, Medellin, Colombia
| | - O Henao
- From McMaster University, Hamilton University Health Network, Hamilton, University of Toronto, Toronto, Ont., and the Hospital Universitario San Vicente Fundacion, Medellin, Colombia
| | - A Okrainec
- From McMaster University, Hamilton University Health Network, Hamilton, University of Toronto, Toronto, Ont., and the Hospital Universitario San Vicente Fundacion, Medellin, Colombia
| | - D Paskar
- From the Department of General Surgery, University of Western Ontario, London, Ont
| | - K Croome
- From the Department of General Surgery, University of Western Ontario, London, Ont
| | - R Hernandez
- From the Department of General Surgery, University of Western Ontario, London, Ont
| | - G Knapp
- From McMaster University, Hamilton, Ont., and Centro Evangelico de Medicina (CEML) Hospital, Lubango, Angola
| | - N Howatt
- From McMaster University, Hamilton, Ont., and Centro Evangelico de Medicina (CEML) Hospital, Lubango, Angola
| | - S Foster
- From McMaster University, Hamilton, Ont., and Centro Evangelico de Medicina (CEML) Hospital, Lubango, Angola
| | - B Cameron
- From McMaster University, Hamilton, Ont., and Centro Evangelico de Medicina (CEML) Hospital, Lubango, Angola
| | - J Austin
- From the Foothills Medical Centre and Tom Baker Cancer Centre, Calgary, Alta
| | - L Mack
- From the Foothills Medical Centre and Tom Baker Cancer Centre, Calgary, Alta
| | - W Temple
- From the Foothills Medical Centre and Tom Baker Cancer Centre, Calgary, Alta
| | - S Puloski
- From the Foothills Medical Centre and Tom Baker Cancer Centre, Calgary, Alta
| | - N Schachar
- From the Foothills Medical Centre and Tom Baker Cancer Centre, Calgary, Alta
| | - T Gill
- From the Surrey Memorial Hospital, New Westminster and Surrey, BC
| | - P Doris
- From the Surrey Memorial Hospital, New Westminster and Surrey, BC
| | - A Tecson
- From the Surrey Memorial Hospital, New Westminster and Surrey, BC
| | - N Kolozsvari
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - A Andalib
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - P Kaneva
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - J Cao
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - M Vassiliou
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - G Fried
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - L Feldman
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - N Kolozsvari
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que
| | - P Kaneva
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que
| | - M Vassiliou
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que
| | - G Fried
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que
| | - L Feldman
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que
| | - N Kolozsvari
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - P Kaneva
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - C Brace
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - G Chartrand
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - M Vaillancourt
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - J Cao
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - D Banaszek
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - M Vassiliou
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - G Fried
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - L Feldman
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - S Fraser
- From the Jewish General Hospital, Montréal, Que
| | - S Bergman
- From the Jewish General Hospital, Montréal, Que
| | - R Deobald
- From the Department of General Surgery and West Winds Primary Health Centre, University of Saskatchewan, Saskatoon, Sask
| | - J Chad
- From the Department of General Surgery and West Winds Primary Health Centre, University of Saskatchewan, Saskatoon, Sask
| | - C Di Gregorio
- From the Department of General Surgery and West Winds Primary Health Centre, University of Saskatchewan, Saskatoon, Sask
| | - J Johnstone
- From the Department of General Surgery and West Winds Primary Health Centre, University of Saskatchewan, Saskatoon, Sask
| | - C Kenyon
- From the Department of General Surgery and West Winds Primary Health Centre, University of Saskatchewan, Saskatoon, Sask
| | - M Lees
- From the Department of General Surgery and West Winds Primary Health Centre, University of Saskatchewan, Saskatoon, Sask
| | - E Auger-Dufour
- From the McGill University Health Centre, McGill University, Montréal, Que
| | - G Fried
- From the McGill University Health Centre, McGill University, Montréal, Que
| | - L Feldman
- From the McGill University Health Centre, McGill University, Montréal, Que
| | - L Ferri
- From the McGill University Health Centre, McGill University, Montréal, Que
| | - M Vassiliou
- From the McGill University Health Centre, McGill University, Montréal, Que
| | - A Alqahtani
- From the Division of Colorectal Surgery, Department of Epidemiology, Division of Gastroenterology of the Jewish General Hospital, McGill University School of Medicine, Montréal, Que
| | - R Perlman
- From the Division of Colorectal Surgery, Department of Epidemiology, Division of Gastroenterology of the Jewish General Hospital, McGill University School of Medicine, Montréal, Que
| | - C Holcroft
- From the Division of Colorectal Surgery, Department of Epidemiology, Division of Gastroenterology of the Jewish General Hospital, McGill University School of Medicine, Montréal, Que
| | - P H Gordon
- From the Division of Colorectal Surgery, Department of Epidemiology, Division of Gastroenterology of the Jewish General Hospital, McGill University School of Medicine, Montréal, Que
| | - A Szilagyi
- From the Division of Colorectal Surgery, Department of Epidemiology, Division of Gastroenterology of the Jewish General Hospital, McGill University School of Medicine, Montréal, Que
| | - D Iradukunda
- From the University of Saskatchewan, Saskatoon, Sask
| | - M A J Moser
- From the University of Saskatchewan, Saskatoon, Sask
| | - N Rodych
- From the University of Saskatchewan, Saskatoon, Sask
| | - J M Shaw
- From the University of Saskatchewan, Saskatoon, Sask
| | - N Ahmed
- From the University of Toronto, Toronto, Ont
| | - M Chiu
- From the University of Toronto, Toronto, Ont
| | - B Kurabi
- From the University of Toronto, Toronto, Ont
| | - A Qureshi
- From the University of Toronto, Toronto, Ont
| | - A Nathens
- From the University of Toronto, Toronto, Ont
| | | | - A Pandya
- From the University of Toronto, Toronto, Ont
| | - S Kitto
- From the University of Toronto, Toronto, Ont
| | - G Ma
- From the University of Toronto, Toronto, Ont
| | - A Pooni
- From the University of Toronto, Toronto, Ont
| | - S Forbes
- From the University of Toronto, Toronto, Ont
| | | | - E Pearsall
- From the University of Toronto, Toronto, Ont
| | - F Brenneman
- From the University of Toronto, Toronto, Ont
| | - R McLeod
- From the University of Toronto, Toronto, Ont
| | - M A Rockx
- From the Alberta Medical Association Locum Services and the University of Western Ontario, London, Ont
| | - V McAlister
- From the Alberta Medical Association Locum Services and the University of Western Ontario, London, Ont
| | - D Roberts
- From the University of Calgary, Calgary, Alta
| | - J Ouellet
- From the University of Calgary, Calgary, Alta
| | | | - R Lall
- From the University of Calgary, Calgary, Alta
| | | | - C Ball
- From the University of Calgary, Calgary, Alta
| | - S Chackungal
- From the University of Western Ontario, London, Ont., the University of British Columbia, Vancouver, BC, the Ministry of Health Liberia, Monrovia, Liberia, and Harvard Humanitarian Initiative, Cambridge, Mass
| | - L M Knowlton
- From the University of Western Ontario, London, Ont., the University of British Columbia, Vancouver, BC, the Ministry of Health Liberia, Monrovia, Liberia, and Harvard Humanitarian Initiative, Cambridge, Mass
| | - B Dahn
- From the University of Western Ontario, London, Ont., the University of British Columbia, Vancouver, BC, the Ministry of Health Liberia, Monrovia, Liberia, and Harvard Humanitarian Initiative, Cambridge, Mass
| | - K McQueen
- From the University of Western Ontario, London, Ont., the University of British Columbia, Vancouver, BC, the Ministry of Health Liberia, Monrovia, Liberia, and Harvard Humanitarian Initiative, Cambridge, Mass
| | - J A Morrison
- From the Chatham Kent Health Alliance, Chatham, Ont
| | - B Lent
- From the University of Western Ontario, London, Ont
| | - J Brown
- From the University of Western Ontario, London, Ont
| | - M Fluit
- From the University of Western Ontario, London, Ont
| | - C Herbert
- From the University of Western Ontario, London, Ont
| | - S Deen
- From the University of Calgary, Calgary, Alta
| | | | - S McFadden
- From the University of Calgary, Calgary, Alta
| | - G Gelfand
- From the University of Calgary, Calgary, Alta
| | - D Bosch
- From the University of Calgary, Calgary, Alta
| | - L Grimmer
- From the Brown University School of Medicine, Providence, RI
| | - S Milman
- From the Brown University School of Medicine, Providence, RI
| | - T Ng
- From the Brown University School of Medicine, Providence, RI
| | - R Gill
- From the University of Alberta, the Cross Cancer Institute, Edmonton, Alta
| | - T Perry
- From the University of Alberta, the Cross Cancer Institute, Edmonton, Alta
| | - J Abele
- From the University of Alberta, the Cross Cancer Institute, Edmonton, Alta
| | - E Bedard
- From the University of Alberta, the Cross Cancer Institute, Edmonton, Alta
| | - D Schiller
- From the University of Alberta, the Cross Cancer Institute, Edmonton, Alta
| | - S Coughlin
- From the University of Western Ontario, London Health Sciences Centre, London, Ont
| | - T Charyk Stewart
- From the University of Western Ontario, London Health Sciences Centre, London, Ont
| | - N Parry
- From the University of Western Ontario, London Health Sciences Centre, London, Ont
| | - D Gray
- From the University of Western Ontario, London Health Sciences Centre, London, Ont
| | - J Williamson
- From the University of Western Ontario, London Health Sciences Centre, London, Ont
| | - R Malthaner
- From the University of Western Ontario, London Health Sciences Centre, London, Ont
| | - D Bottoni
- From the London Health Sciences Centre and CSTAR, London, Ont
| | - M Perri
- From the London Health Sciences Centre and CSTAR, London, Ont
| | - A L Trejos
- From the London Health Sciences Centre and CSTAR, London, Ont
| | - M Naish
- From the London Health Sciences Centre and CSTAR, London, Ont
| | - R Patel
- From the London Health Sciences Centre and CSTAR, London, Ont
| | - R Malthaner
- From the London Health Sciences Centre and CSTAR, London, Ont
| | - A Ashrafi
- From the Surrey Memorial Hospital, Surrey, BC
| | - J Bond
- From the Surrey Memorial Hospital, Surrey, BC
| | - S Ong
- From the Surrey Memorial Hospital, Surrey, BC
| | - M Yamashita
- From the Surrey Memorial Hospital, Surrey, BC
| | - S Ahmadi
- From the Surrey Memorial Hospital, Surrey, BC
| | | | - J Miller
- From McMaster University, Hamilton, Ont
| | - C Finley
- From McMaster University, Hamilton, Ont
| | | | | | - L Lee
- From the McGill University Health Centre, Montréal, Que
| | - S Hanley
- From the McGill University Health Centre, Montréal, Que
| | - C Robineau
- From the McGill University Health Centre, Montréal, Que
| | - C Sirois
- From the McGill University Health Centre, Montréal, Que
| | - D Mulder
- From the McGill University Health Centre, Montréal, Que
| | - L Ferri
- From the McGill University Health Centre, Montréal, Que
| | - R Humphrey
- From the University of Western Ontario, Woodstock, and London, Ont
| | - R Inculet
- From the University of Western Ontario, Woodstock, and London, Ont
| | - D Fortin
- From the University of Western Ontario, Woodstock, and London, Ont
| | - A Arab
- From the University of Western Ontario, Woodstock, and London, Ont
| | - R Malthaner
- From the University of Western Ontario, Woodstock, and London, Ont
| | - A Ashrafi
- From the Surrey Memorial Hospital, Surrey, BC
| | - J Bond
- From the Surrey Memorial Hospital, Surrey, BC
| | - S Ong
- From the Surrey Memorial Hospital, Surrey, BC
| | - M Yamashita
- From the Surrey Memorial Hospital, Surrey, BC
| | - S Ahmadi
- From the Surrey Memorial Hospital, Surrey, BC
| | - A McGuire
- From Queen's University, Ottawa and Kingston, Ont
| | - K Reid
- From Queen's University, Ottawa and Kingston, Ont
| | - D Petsikas
- From Queen's University, Ottawa and Kingston, Ont
| | - W Hopman
- From Queen's University, Ottawa and Kingston, Ont
| | - A Basi
- From the University of Western Ontario, London, and the William Osler Health Centre, Brampton, Ont
| | - S Basi
- From the University of Western Ontario, London, and the William Osler Health Centre, Brampton, Ont
| | - K Irshad
- From the University of Western Ontario, London, and the William Osler Health Centre, Brampton, Ont
| | - W Hanna
- From the Toronto General Hospital, Toronto, Ont
| | - K P Croome
- From the University of Western Ontario, London, Ont
| | - P Marotta
- From the University of Western Ontario, London, Ont
| | - V McAlister
- From the University of Western Ontario, London, Ont
| | - D Quan
- From the University of Western Ontario, London, Ont
| | - W Wall
- From the University of Western Ontario, London, Ont
| | | | - C de Mestral
- From the Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto and Institute for Clinical Evaluative Sciences, Toronto, Ont
| | - B Zagorski
- From the Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto and Institute for Clinical Evaluative Sciences, Toronto, Ont
| | - O Rotstein
- From the Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto and Institute for Clinical Evaluative Sciences, Toronto, Ont
| | - D Gomez
- From the Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto and Institute for Clinical Evaluative Sciences, Toronto, Ont
| | - B Haas
- From the Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto and Institute for Clinical Evaluative Sciences, Toronto, Ont
| | - A Laupacis
- From the Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto and Institute for Clinical Evaluative Sciences, Toronto, Ont
| | - S Sharma
- From the Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto and Institute for Clinical Evaluative Sciences, Toronto, Ont
| | - J Bridge
- From the Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto and Institute for Clinical Evaluative Sciences, Toronto, Ont
| | - A Nathens
- From the Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto and Institute for Clinical Evaluative Sciences, Toronto, Ont
| | - F Bhojani
- From the University of Toronto, Toronto, Ont
| | - A Fox
- From the University of Toronto, Toronto, Ont
| | - K Pitzul
- From the University of Toronto, Toronto, Ont
| | - C-A Moulton
- From the University of Toronto, Toronto, Ont
| | - A Wei
- From the University of Toronto, Toronto, Ont
| | - A Okrainec
- From the University of Toronto, Toronto, Ont
| | - S Cleary
- From the University of Toronto, Toronto, Ont
| | - K Bertens
- From the University of Western Ontario, London, Ont
| | - K P Croome
- From the University of Western Ontario, London, Ont
| | - A Mujoomdar
- From the University of Western Ontario, London, Ont
| | - D Peck
- From the University of Western Ontario, London, Ont
| | - R Rankin
- From the University of Western Ontario, London, Ont
| | - D Quan
- From the University of Western Ontario, London, Ont
| | - N Kakani
- From the University of Western Ontario, London, Ont
| | | | - R Suri
- From McMaster University, Hamilton, Ont
| | | | - L Ruo
- From McMaster University, Hamilton, Ont
| | - M Jamal
- From McGill University, Montréal, Que., and University of Queensland, School of Public Health, Brisbane, Queensland, Australia
| | - J Abou Khalil
- From McGill University, Montréal, Que., and University of Queensland, School of Public Health, Brisbane, Queensland, Australia
| | - E Simoneau-Beaudry
- From McGill University, Montréal, Que., and University of Queensland, School of Public Health, Brisbane, Queensland, Australia
| | - S Dumitra
- From McGill University, Montréal, Que., and University of Queensland, School of Public Health, Brisbane, Queensland, Australia
| | - M Edwards
- From McGill University, Montréal, Que., and University of Queensland, School of Public Health, Brisbane, Queensland, Australia
| | - Y Yousef
- From McGill University, Montréal, Que., and University of Queensland, School of Public Health, Brisbane, Queensland, Australia
| | - M Al Jiffry
- From McGill University, Montréal, Que., and University of Queensland, School of Public Health, Brisbane, Queensland, Australia
| | - P Metrakos
- From McGill University, Montréal, Que., and University of Queensland, School of Public Health, Brisbane, Queensland, Australia
| | - J Tchervenkov
- From McGill University, Montréal, Que., and University of Queensland, School of Public Health, Brisbane, Queensland, Australia
| | - S Doi
- From McGill University, Montréal, Que., and University of Queensland, School of Public Health, Brisbane, Queensland, Australia
| | - J Barkun
- From McGill University, Montréal, Que., and University of Queensland, School of Public Health, Brisbane, Queensland, Australia
| | - A Obayan
- From the Department of Surgery, University of Saskatchewan, Saskatoon, Sask., and the Regina General Hospital, Regina, Sask
| | - S Meiers
- From the Department of Surgery, University of Saskatchewan, Saskatoon, Sask., and the Regina General Hospital, Regina, Sask
| | - R Keith
- From the Department of Surgery, University of Saskatchewan, Saskatoon, Sask., and the Regina General Hospital, Regina, Sask
| | - S Elkassem
- From the University of Toronto, Toronto, Ont., and the University of Calgary, Calgary, Alta
| | - N Church
- From the University of Toronto, Toronto, Ont., and the University of Calgary, Calgary, Alta
| | - P Mitchell
- From the University of Toronto, Toronto, Ont., and the University of Calgary, Calgary, Alta
| | - C Turbide
- From the University of Toronto, Toronto, Ont., and the University of Calgary, Calgary, Alta
| | - E Dixon
- From the University of Toronto, Toronto, Ont., and the University of Calgary, Calgary, Alta
| | - E Debru
- From the University of Toronto, Toronto, Ont., and the University of Calgary, Calgary, Alta
| | - J Shum
- From the University of Western Ontario, London, Ont
| | - W J Wall
- From the University of Western Ontario, London, Ont
| | - R Maniar
- From the University of Manitoba, Winnipeg, Man
| | - D Hochman
- From the University of Manitoba, Winnipeg, Man
| | - D Wirtzfeld
- From the University of Manitoba, Winnipeg, Man
| | - C Yaffe
- From the University of Manitoba, Winnipeg, Man
| | - B Yip
- From the University of Manitoba, Winnipeg, Man
| | - A McKay
- From the University of Manitoba, Winnipeg, Man
| | - R Silverman
- From the University of Manitoba, Winnipeg, Man
| | - J Park
- From the University of Manitoba, Winnipeg, Man
| | - V Francescutti
- From the Roswell Park Cancer Institute, Buffalo, New York, NY
| | - L Rivera
- From the Roswell Park Cancer Institute, Buffalo, New York, NY
| | - J M Kane
- From the Roswell Park Cancer Institute, Buffalo, New York, NY
| | - J J Skitzki
- From the Roswell Park Cancer Institute, Buffalo, New York, NY
| | - P Lovrics
- From McMaster University, Hamilton, Ont
| | - N Hodgson
- From McMaster University, Hamilton, Ont
| | | | - L Thabane
- From McMaster University, Hamilton, Ont
| | | | - B Heller
- From McMaster University, Hamilton, Ont
| | - S Reid
- From McMaster University, Hamilton, Ont
| | - K Sanders
- From McMaster University, Hamilton, Ont
| | - T Kittmer
- From McMaster University, Hamilton, Ont
| | | | - S Duhaime
- From the University of Ottawa, Ottawa, Ont., and The Ottawa Hospital, Ottawa, Ont
| | - B Fong
- From the University of Ottawa, Ottawa, Ont., and The Ottawa Hospital, Ottawa, Ont
| | - M Deria
- From the University of Ottawa, Ottawa, Ont., and The Ottawa Hospital, Ottawa, Ont
| | - C Acton
- From the University of Ottawa, Ottawa, Ont., and The Ottawa Hospital, Ottawa, Ont
| | - M El-Maadawy
- From the University of Ottawa, Ottawa, Ont., and The Ottawa Hospital, Ottawa, Ont
| | - S Lad
- From the University of Ottawa, Ottawa, Ont., and The Ottawa Hospital, Ottawa, Ont
| | - A Arnaout
- From the University of Ottawa, Ottawa, Ont., and The Ottawa Hospital, Ottawa, Ont
| | - M Omole
- From McMaster University, Hamilton, Ont
| | | | - P Lovrics
- From McMaster University, Hamilton, Ont
| | - D Bischof
- From North York General Hospital, Mount Sinai Hospital, Humber River Regional Hospital and the University of Toronto, Toronto, Ont
| | - P Stotland
- From North York General Hospital, Mount Sinai Hospital, Humber River Regional Hospital and the University of Toronto, Toronto, Ont
| | - J Hagen
- From North York General Hospital, Mount Sinai Hospital, Humber River Regional Hospital and the University of Toronto, Toronto, Ont
| | - C Swallow
- From North York General Hospital, Mount Sinai Hospital, Humber River Regional Hospital and the University of Toronto, Toronto, Ont
| | - L Klein
- From North York General Hospital, Mount Sinai Hospital, Humber River Regional Hospital and the University of Toronto, Toronto, Ont
| | - J A Van Koughnett
- From the Division of General Surgery, University of Western Ontario, and the London Regional Cancer Program, London, Ont
| | - T Ahmad
- From the Division of General Surgery, University of Western Ontario, and the London Regional Cancer Program, London, Ont
| | - P Ainsworth
- From the Division of General Surgery, University of Western Ontario, and the London Regional Cancer Program, London, Ont
| | - M Brackstone
- From the Division of General Surgery, University of Western Ontario, and the London Regional Cancer Program, London, Ont
| | | | - G Groot
- From the University of Saskatchewan, Saskatoon, Sask
| | | | | | | | - B Strang
- From McMaster University, Hamilton, Ont
| | | | - S MacLellan
- From the Department of Radiology, Department of Surgery, Princess Margaret Hospital, University Health Network, University of Toronto, Cancer Care Ontario, Toronto, Ont
| | - H MacKay
- From the Department of Radiology, Department of Surgery, Princess Margaret Hospital, University Health Network, University of Toronto, Cancer Care Ontario, Toronto, Ont
| | - J Ringash
- From the Department of Radiology, Department of Surgery, Princess Margaret Hospital, University Health Network, University of Toronto, Cancer Care Ontario, Toronto, Ont
| | - L Jacks
- From the Department of Radiology, Department of Surgery, Princess Margaret Hospital, University Health Network, University of Toronto, Cancer Care Ontario, Toronto, Ont
| | - Z Kassam
- From the Department of Radiology, Department of Surgery, Princess Margaret Hospital, University Health Network, University of Toronto, Cancer Care Ontario, Toronto, Ont
| | - I Khalili
- From the Department of Radiology, Department of Surgery, Princess Margaret Hospital, University Health Network, University of Toronto, Cancer Care Ontario, Toronto, Ont
| | - T Conrad
- From the Department of Radiology, Department of Surgery, Princess Margaret Hospital, University Health Network, University of Toronto, Cancer Care Ontario, Toronto, Ont
| | - A Okrainec
- From the Department of Radiology, Department of Surgery, Princess Margaret Hospital, University Health Network, University of Toronto, Cancer Care Ontario, Toronto, Ont
| | - R Chagpar
- From the University of Western Ontario, London, Ont., and the MD Anderson Cancer Center, Houston, Tex
| | - Y Xing
- From the University of Western Ontario, London, Ont., and the MD Anderson Cancer Center, Houston, Tex
| | - N You
- From the University of Western Ontario, London, Ont., and the MD Anderson Cancer Center, Houston, Tex
| | - C Yi-Ju
- From the University of Western Ontario, London, Ont., and the MD Anderson Cancer Center, Houston, Tex
| | - B Feig
- From the University of Western Ontario, London, Ont., and the MD Anderson Cancer Center, Houston, Tex
| | - G Chang
- From the University of Western Ontario, London, Ont., and the MD Anderson Cancer Center, Houston, Tex
| | - J Cormie
- From the University of Western Ontario, London, Ont., and the MD Anderson Cancer Center, Houston, Tex
| | - M-K Gervais
- From Hôpital Maisonneuve-Rosemont, Montréal, Que
| | - L Sideris
- From Hôpital Maisonneuve-Rosemont, Montréal, Que
| | - P Drolet
- From Hôpital Maisonneuve-Rosemont, Montréal, Que
| | - A Mitchell
- From Hôpital Maisonneuve-Rosemont, Montréal, Que
| | - G Leblanc
- From Hôpital Maisonneuve-Rosemont, Montréal, Que
| | - P Dubé
- From Hôpital Maisonneuve-Rosemont, Montréal, Que
| | - S Merchant
- From the University of British Columbia, General Surgery, and the BC Cancer Agency, Vancouver, BC
| | - M Knowling
- From the University of British Columbia, General Surgery, and the BC Cancer Agency, Vancouver, BC
| | - R Cheifetz
- From the University of British Columbia, General Surgery, and the BC Cancer Agency, Vancouver, BC
| | - M Raval
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC
| | - B Heidary
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC
| | - S Kalikias
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC
| | - D Raval
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC
| | - T Phang
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC
| | - C Brown
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC
| | - A Scheer
- From The Ottawa Hospital, University of Ottawa, Ottawa, Ont
| | - A O'Connor
- From The Ottawa Hospital, University of Ottawa, Ottawa, Ont
| | - B Chan
- From The Ottawa Hospital, University of Ottawa, Ottawa, Ont
| | - H Moloo
- From The Ottawa Hospital, University of Ottawa, Ottawa, Ont
| | - E Poulin
- From The Ottawa Hospital, University of Ottawa, Ottawa, Ont
| | - J Mamazza
- From The Ottawa Hospital, University of Ottawa, Ottawa, Ont
| | - R Auer
- From The Ottawa Hospital, University of Ottawa, Ottawa, Ont
| | - R Boushey
- From The Ottawa Hospital, University of Ottawa, Ottawa, Ont
| | - K Hardy
- From the University of Manitoba, Winnipeg, Man., and the University of Toronto, Toronto, Ont
| | - A Vergis
- From the University of Manitoba, Winnipeg, Man., and the University of Toronto, Toronto, Ont
| | - P Sullivan
- From the University of Manitoba, Winnipeg, Man., and the University of Toronto, Toronto, Ont
| | - R Musselman
- From The Ottawa Hospital, University of Ottawa, Ottawa, Institute for Clinical Evaluative Sciences, Li Ka Shing Knowledge Institute of St. Michael's, Toronto, Ont., and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
| | - T Gomes
- From The Ottawa Hospital, University of Ottawa, Ottawa, Institute for Clinical Evaluative Sciences, Li Ka Shing Knowledge Institute of St. Michael's, Toronto, Ont., and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
| | - B Chan
- From The Ottawa Hospital, University of Ottawa, Ottawa, Institute for Clinical Evaluative Sciences, Li Ka Shing Knowledge Institute of St. Michael's, Toronto, Ont., and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
| | - R Auer
- From The Ottawa Hospital, University of Ottawa, Ottawa, Institute for Clinical Evaluative Sciences, Li Ka Shing Knowledge Institute of St. Michael's, Toronto, Ont., and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
| | - H Moloo
- From The Ottawa Hospital, University of Ottawa, Ottawa, Institute for Clinical Evaluative Sciences, Li Ka Shing Knowledge Institute of St. Michael's, Toronto, Ont., and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
| | - E Poulin
- From The Ottawa Hospital, University of Ottawa, Ottawa, Institute for Clinical Evaluative Sciences, Li Ka Shing Knowledge Institute of St. Michael's, Toronto, Ont., and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
| | - J Mamazza
- From The Ottawa Hospital, University of Ottawa, Ottawa, Institute for Clinical Evaluative Sciences, Li Ka Shing Knowledge Institute of St. Michael's, Toronto, Ont., and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
| | - K Al-Khayal
- From The Ottawa Hospital, University of Ottawa, Ottawa, Institute for Clinical Evaluative Sciences, Li Ka Shing Knowledge Institute of St. Michael's, Toronto, Ont., and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
| | - M Al-Omran
- From The Ottawa Hospital, University of Ottawa, Ottawa, Institute for Clinical Evaluative Sciences, Li Ka Shing Knowledge Institute of St. Michael's, Toronto, Ont., and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
| | - M Mamdani
- From The Ottawa Hospital, University of Ottawa, Ottawa, Institute for Clinical Evaluative Sciences, Li Ka Shing Knowledge Institute of St. Michael's, Toronto, Ont., and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
| | - O AlObeed
- From The Ottawa Hospital, University of Ottawa, Ottawa, Institute for Clinical Evaluative Sciences, Li Ka Shing Knowledge Institute of St. Michael's, Toronto, Ont., and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
| | - R Boushey
- From The Ottawa Hospital, University of Ottawa, Ottawa, Institute for Clinical Evaluative Sciences, Li Ka Shing Knowledge Institute of St. Michael's, Toronto, Ont., and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
| | - G Martel
- From the University of Ottawa, Ottawa, Ont., McGill University, Montréal, Que., and the University of Aberdeen, Aberdeen, Great Britain
| | - A Crawford
- From the University of Ottawa, Ottawa, Ont., McGill University, Montréal, Que., and the University of Aberdeen, Aberdeen, Great Britain
| | - J Barkun
- From the University of Ottawa, Ottawa, Ont., McGill University, Montréal, Que., and the University of Aberdeen, Aberdeen, Great Britain
| | - C Ramsay
- From the University of Ottawa, Ottawa, Ont., McGill University, Montréal, Que., and the University of Aberdeen, Aberdeen, Great Britain
| | - D Fergusson
- From the University of Ottawa, Ottawa, Ont., McGill University, Montréal, Que., and the University of Aberdeen, Aberdeen, Great Britain
| | - R Boushey
- From the University of Ottawa, Ottawa, Ont., McGill University, Montréal, Que., and the University of Aberdeen, Aberdeen, Great Britain
| | - L Williams
- From the University of Ottawa, Ottawa, Ont
| | - A Crawford
- From the University of Ottawa, Ottawa, Ont
| | | | - M Mackey
- From the University of Ottawa, Ottawa, Ont
| | - H Moloo
- From the University of Ottawa, Ottawa, Ont
| | - J Mamazza
- From the University of Ottawa, Ottawa, Ont
| | - E Poulin
- From the University of Ottawa, Ottawa, Ont
| | | | - R Boushey
- From the University of Ottawa, Ottawa, Ont
| | - R Auer
- From the University of Ottawa, Ottawa, Ont
| | - F Bellolio
- From the University of Toronto, Toronto, Ont
| | - Z Cohen
- From the University of Toronto, Toronto, Ont
| | - H MacRae
- From the University of Toronto, Toronto, Ont
| | - B O'Connor
- From the University of Toronto, Toronto, Ont
| | - H Huang
- From the University of Toronto, Toronto, Ont
| | - J C Victor
- From the University of Toronto, Toronto, Ont
| | - R McLeod
- From the University of Toronto, Toronto, Ont
| | - K Hardy
- From the University of Manitoba, Winnipeg, Man., the University of Toronto, Toronto, and Queen's University, Kingston, Ont
| | - K Pitzul
- From the University of Manitoba, Winnipeg, Man., the University of Toronto, Toronto, and Queen's University, Kingston, Ont
| | - J Kwong
- From the University of Manitoba, Winnipeg, Man., the University of Toronto, Toronto, and Queen's University, Kingston, Ont
| | - A Vergis
- From the University of Manitoba, Winnipeg, Man., the University of Toronto, Toronto, and Queen's University, Kingston, Ont
| | - D Urbach
- From the University of Manitoba, Winnipeg, Man., the University of Toronto, Toronto, and Queen's University, Kingston, Ont
| | - A Okrainec
- From the University of Manitoba, Winnipeg, Man., the University of Toronto, Toronto, and Queen's University, Kingston, Ont
| | - K Vogt
- From the London Health Sciences Centre, London, Ont
| | - L Dubois
- From the London Health Sciences Centre, London, Ont
| | - C Vinden
- From the London Health Sciences Centre, London, Ont
| | - B Chan
- From the University of Ottawa, Ottawa, Ont
| | - A Scheer
- From the University of Ottawa, Ottawa, Ont
| | - A Menezes
- From the University of Ottawa, Ottawa, Ont
| | - H Moloo
- From the University of Ottawa, Ottawa, Ont
| | - E Poulin
- From the University of Ottawa, Ottawa, Ont
| | - R Boushey
- From the University of Ottawa, Ottawa, Ont
| | - J Mamazza
- From the University of Ottawa, Ottawa, Ont
| | - F Bellolio
- From the University of Toronto, Toronto, Ont
| | - H MacRae
- From the University of Toronto, Toronto, Ont
| | - Z Cohen
- From the University of Toronto, Toronto, Ont
| | - B O'Connor
- From the University of Toronto, Toronto, Ont
| | - H Huang
- From the University of Toronto, Toronto, Ont
| | - R McLeod
- From the University of Toronto, Toronto, Ont
| | - C Godbout-Simard
- From the McGill Medical School, JSS Medical Research, Jewish General Hospital, Montréal, Que
| | - J Azar
- From the McGill Medical School, JSS Medical Research, Jewish General Hospital, Montréal, Que
| | - F Psaradellis
- From the McGill Medical School, JSS Medical Research, Jewish General Hospital, Montréal, Que
| | - J Sampalis
- From the McGill Medical School, JSS Medical Research, Jewish General Hospital, Montréal, Que
| | - N Morin
- From the McGill Medical School, JSS Medical Research, Jewish General Hospital, Montréal, Que
| | - C Brown
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC
| | - S Kalikias
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC
| | - B Heidary
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC
| | - D Raval
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC
| | - P T Phang
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC
| | - M Raval
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC
| | - A Archibald
- From the Department of Pathology and the Gastrointestinal Diseases Research Unit, Queen's University, Kingston, Ont
| | - D Hurlbut
- From the Department of Pathology and the Gastrointestinal Diseases Research Unit, Queen's University, Kingston, Ont
| | - S Vanner
- From the Department of Pathology and the Gastrointestinal Diseases Research Unit, Queen's University, Kingston, Ont
| | - C Zalai
- From McGill University, Montréal, Que
| | | | - M Simunovic
- From the Juravinski Cancer Centre, McMaster University, Hamilton, Ont
| | - M Cadeddu
- From the Juravinski Cancer Centre, McMaster University, Hamilton, Ont
| | - S Forbes
- From the Juravinski Cancer Centre, McMaster University, Hamilton, Ont
| | - S Kelly
- From the Juravinski Cancer Centre, McMaster University, Hamilton, Ont
| | - W Stephen
- From the Juravinski Cancer Centre, McMaster University, Hamilton, Ont
| | - V Grubac
- From the Juravinski Cancer Centre, McMaster University, Hamilton, Ont
| | - M Marcinow
- From the Juravinski Cancer Centre, McMaster University, Hamilton, Ont
| | - A Coates
- From the Juravinski Cancer Centre, McMaster University, Hamilton, Ont
| | - N Aslani
- From the University of British Columbia, Department of Surgery, St. Paul's Hospital, Vancouver, BC
| | - P T Phang
- From the University of British Columbia, Department of Surgery, St. Paul's Hospital, Vancouver, BC
| | - M Raval
- From the University of British Columbia, Department of Surgery, St. Paul's Hospital, Vancouver, BC
| | - C Brown
- From the University of British Columbia, Department of Surgery, St. Paul's Hospital, Vancouver, BC
| | - A Scheer
- From The Ottawa Hospital, Ottawa, Ont
| | - M Carrier
- From The Ottawa Hospital, Ottawa, Ont
| | - R Boushey
- From The Ottawa Hospital, Ottawa, Ont
| | - T Asmis
- From The Ottawa Hospital, Ottawa, Ont
| | - P Wells
- From The Ottawa Hospital, Ottawa, Ont
| | - D Jonker
- From The Ottawa Hospital, Ottawa, Ont
| | - R Auer
- From The Ottawa Hospital, Ottawa, Ont
| | - N Azer
- From the University of Alberta, Royal Alexandra Hospital, Edmonton, Alta
| | - R Gill
- From the University of Alberta, Royal Alexandra Hospital, Edmonton, Alta
| | - C de Gara
- From the University of Alberta, Royal Alexandra Hospital, Edmonton, Alta
| | - D W Birch
- From the University of Alberta, Royal Alexandra Hospital, Edmonton, Alta
| | - S Karmali
- From the University of Alberta, Royal Alexandra Hospital, Edmonton, Alta
| | - G Roxin
- From the University of Calgary, Calgary, Alta
| | - S Drolet
- From the University of Calgary, Calgary, Alta
| | - A MacLean
- From the University of Calgary, Calgary, Alta
| | - W D Buie
- From the University of Calgary, Calgary, Alta
| | - J Heine
- From the University of Calgary, Calgary, Alta
| | - J Agzarian
- From McMaster University Hamilton, Ont., and the Harvard School of Public Health, Boston, Mass
| | - S Forbes
- From McMaster University Hamilton, Ont., and the Harvard School of Public Health, Boston, Mass
| | - W Stephen
- From McMaster University Hamilton, Ont., and the Harvard School of Public Health, Boston, Mass
| | - S Kelly
- From McMaster University Hamilton, Ont., and the Harvard School of Public Health, Boston, Mass
| | - P Churchill
- From McMaster University, Hamilton Health Sciences Hamilton, Ont
| | - T Corner
- From McMaster University, Hamilton Health Sciences Hamilton, Ont
| | - S Kelly
- From McMaster University, Hamilton Health Sciences Hamilton, Ont
| | - S Forbes
- From McMaster University, Hamilton Health Sciences Hamilton, Ont
| | - L Lindsay
- From McMaster University, Hamilton Health Sciences Hamilton, Ont
| | - W Stephen
- From McMaster University, Hamilton Health Sciences Hamilton, Ont
| | - A Scheer
- From The University of Ottawa, The Ottawa Hospital, Ottawa, Ont
| | - A O'Connor
- From The University of Ottawa, The Ottawa Hospital, Ottawa, Ont
| | - B Chan
- From The University of Ottawa, The Ottawa Hospital, Ottawa, Ont
| | - H Moloo
- From The University of Ottawa, The Ottawa Hospital, Ottawa, Ont
| | - E Poulin
- From The University of Ottawa, The Ottawa Hospital, Ottawa, Ont
| | - J Mamazza
- From The University of Ottawa, The Ottawa Hospital, Ottawa, Ont
| | - R Auer
- From The University of Ottawa, The Ottawa Hospital, Ottawa, Ont
| | - R Boushey
- From The University of Ottawa, The Ottawa Hospital, Ottawa, Ont
| | - J Denis
- From the Winnipeg Regional Health Authority, University of Manitoba, Winnipeg, Man
| | - D Hochman
- From the Winnipeg Regional Health Authority, University of Manitoba, Winnipeg, Man
| | - M Recsky
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, and the BC Cancer Agency, Vancouver, BC
| | - P T Phang
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, and the BC Cancer Agency, Vancouver, BC
| | - M Raval
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, and the BC Cancer Agency, Vancouver, BC
| | - W Cheung
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, and the BC Cancer Agency, Vancouver, BC
| | - C Brown
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, and the BC Cancer Agency, Vancouver, BC
| | - N Alkhamesi
- From Canadian Surgical Technologies and Advanced Robotics, London, Ont
| | - C M Schlachta
- From Canadian Surgical Technologies and Advanced Robotics, London, Ont
| | - T Tiwari
- From the Department of Surgery, St. Paul's Hospital, Vancouver, BC
| | - C Brown
- From the Department of Surgery, St. Paul's Hospital, Vancouver, BC
| | - M J Raval
- From the Department of Surgery, St. Paul's Hospital, Vancouver, BC
| | - P T Phang
- From the Department of Surgery, St. Paul's Hospital, Vancouver, BC
| |
Collapse
|
45
|
Gonzalez-Rey M, Lau TC, Gomes T, Maria VL, Bebianno MJ, Wu R. Comparison of metal accumulation between 'Artificial Mussel' and natural mussels (Mytilus galloprovincialis) in marine environments. Mar Pollut Bull 2011; 63:149-153. [PMID: 21237472 DOI: 10.1016/j.marpolbul.2010.12.007] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/29/2010] [Revised: 11/26/2010] [Accepted: 12/05/2010] [Indexed: 05/30/2023]
Abstract
The passive sampler called 'Artificial Mussel' (AM) developed by Wu et al. (2007) can provide a time-integrated estimate of metal concentrations in the marine environment, and offers a potential device to assess and compare metal concentration in different marine environments worldwide. The aim of this study was to compare metal accumulation on AM and natural mussel Mytilus galloprovincialis at three sites with different metal loads along the Portuguese coast for four months. M. galloprovincialis were placed in cages alongside AMs at each site. Samples were collected monthly and Cd, Cr, Cu, Pb, and Zn concentrations in whole soft tissues and AMs compared. For both Cu and Cd, the results were similar between AMs and natural mussels. Higher concentrations of Zn were observed in natural mussels, whereas the inverse was shown for Pb (about 10-fold higher). Our results showed that AMs are promising tools for assessing metal concentrations in marine environments.
Collapse
Affiliation(s)
- M Gonzalez-Rey
- CIMA, Centre of Marine and Environmental Research, Campus de Gambelas, Faculty of Science and Technology, University of Algarve, Faro, Portugal
| | | | | | | | | | | |
Collapse
|
46
|
Geret F, Gomes T, Marty P, Bebianno M. Differential protein expression in Corbicula fluminea exposed to a mixture of pharmaceutical products. Comp Biochem Physiol A Mol Integr Physiol 2010. [DOI: 10.1016/j.cbpa.2010.06.133] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
47
|
Maria V, Gomes T, Bebianno M. Protein expression profiles in Mytilus galloprovincialis exposed to a combination of contaminants. Comp Biochem Physiol A Mol Integr Physiol 2010. [DOI: 10.1016/j.cbpa.2010.06.130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
48
|
Gomes T, Cancio I, Pinheiro J, Bebianno M. Integration of conventional biomarkers and proteomic analysis to assess the effects of copper nanoparticles in Mytilus galloprovincialis. Comp Biochem Physiol A Mol Integr Physiol 2010. [DOI: 10.1016/j.cbpa.2010.06.152] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
49
|
Kelly CM, Gomes T, Duong-Hua M, Pritchard KI, Paszat LF, Juurlink DN. Patterns of antidepressant use among women initiating tamoxifen therapy for the treatment of breast cancer in Ontario, Canada. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.1592] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
50
|
Kelly C, Kelly C, Kelly C, Juurlink D, Juurlink D, Juurlink D, Gomes T, Duong-Hua M, Pritchard K, Pritchard K, Pritchard K, Austin P, Austin P, Austin P, Paszat L, Paszat L, Paszat L. Risk of Death Due to Breast Cancer in Women Treated with Selective Serotonin Reuptake Inhibitor Antidepressants and Tamoxifen. Cancer Res 2009. [DOI: 10.1158/0008-5472.sabcs-09-2049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Tamoxifen is widely prescribed to women with breast cancer, but is a prodrug converted by cytochrome P450 2D6 (CYP 2D6) to its active metabolite endoxifen. Selective serotonin re-uptake inhibitor antidepressants (SSRIs) are commonly co-prescribed with tamoxifen, but inhibit CYP 2D6 to varying degrees and may decrease the effectiveness of tamoxifen.Materials and methods: We conducted a population-based retrospective cohort study of women in Ontario, Canada aged 66 years of age or older who were treated with tamoxifen for breast cancer between 1993 and 2005 and had overlapping SSRI therapy. Following completion of tamoxifen therapy, we modeled the risk of death from breast cancer as a function of the proportion of time on tamoxifen during which each SSRI had been co-prescribed.Results: We identified 24,430 women aged 66 years and older who started tamoxifen therapy during the 13 year study period. Of these, 7489 (30.6%) received at least one antidepressant during tamoxifen therapy. After excluding those treated with no SSRI or with multiple SSRIs, those with poor adherence to tamoxifen therapy, and those with unknown cause of death, the primary analysis included 2430 women. Paroxetine was the most commonly prescribed SSRI (n=630; 25.9%) followed by sertraline (n=541; 22.3%), citalopram (n=467; 19.2%), venlafaxine (n=365; 15.0%) fluoxetine (n=253; 10.4%) and fluvoxamine (n=174; 7.2%). A total of 1074 (44.2%) women died during follow-up and there were 374 (34.8%) breast cancer deaths. After adjustment for age, duration of tamoxifen therapy, and other potential confounders absolute increases of 25%, 50%, and 75% in the percentage of time co-prescribed paroxetine during tamoxifen therapy were associated with 24%, 54% and 91% increases in the risk of death from breast cancer respectively (p<0.05 for each comparison). In contrast, we found no such risk with fluoxetine, sertraline, fluvoxamine or citalopram. We observed a nonsignificant trend toward reduced breast cancer mortality among venlafaxine users, which may reflect the common practice of using venlafaxine for tamoxifen-related hot flashes, a putative predictor of better outcomes in women receiving tamoxifen. We replicated our analyses using death from any cause as the outcome of interest (n=1074). After adjusting for potential confounders, we found that absolute increases of 25%, 50% and 75% in paroxetine exposure during tamoxifen therapy were associated with relative increases of 13%, 28% and 46%, respectively, in the risk of death from any cause. In contrast, we found no such increased risk in all-cause mortality associated with exposure to the other SSRIs in women receiving tamoxifen for breast cancer.Discussion: Paroxetine use during tamoxifen therapy is associated with an increased risk of death due to breast cancer. This supports the hypothesis that paroxetine-mediated CYP 2D6 inhibition can reduce or abolish the beneficial effects of tamoxifen.
Citation Information: Cancer Res 2009;69(24 Suppl):Abstract nr 2049.
Collapse
Affiliation(s)
- C. Kelly
- 1Institute of Clinical Evaluative Sciences, ON, Canada
| | - C. Kelly
- 2Sunnybrook Health Sciences Centre, ON, Canada
| | - C. Kelly
- 4University of Toronto, ON, Canada
| | - D. Juurlink
- 1Institute of Clinical Evaluative Sciences, ON, Canada
| | - D. Juurlink
- 2Sunnybrook Health Sciences Centre, ON, Canada
| | | | - T. Gomes
- 1Institute of Clinical Evaluative Sciences, ON, Canada
| | - M. Duong-Hua
- 1Institute of Clinical Evaluative Sciences, ON, Canada
| | - K. Pritchard
- 1Institute of Clinical Evaluative Sciences, ON, Canada
| | | | | | - P. Austin
- 1Institute of Clinical Evaluative Sciences, ON, Canada
| | | | | | - L. Paszat
- 1Institute of Clinical Evaluative Sciences, ON, Canada
| | | | | |
Collapse
|